Processing 00000000.tx.1: Journal of Histochemistry and Cytochemistry, Vol. 

Phrase: "Journal of Histochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Cytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010741:Cytochemistry [Biomedical Occupation or Discipline]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.2: 50, 99-106, January 2002, Copyright  2002, The Histochemical Society, Inc. 

Phrase: "50,"

Phrase: "99-106,"

Phrase: "January 2002,"

Phrase: "Copyright  2002,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009993:Copyright [Intellectual Product]
   861   C1552856:copyright [Idea or Concept]

Phrase: "The Histochemical Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "Inc."
Processing 00000000.tx.3: ARTICLE Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease Julie A. 

Phrase: "ARTICLE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "Improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "Detection of Substantia Nigra Pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in Alzheimer's Disease Julie A."
Processing 00000000.tx.4: Schneidera,c, Julia L. 

Phrase: "Schneidera,"

Phrase: "c,"

Phrase: "Julia L."
Processing 00000000.tx.5: Bieniasb, David W. 

Phrase: "Bieniasb,"

Phrase: "David W."
Processing 00000000.tx.6: Gilleyb,c, David E. 

Phrase: "Gilleyb,"

Phrase: "c,"

Phrase: "David E."
Processing 00000000.tx.7: Kvarnberga, Elliott J. 

Phrase: "Kvarnberga,"

Phrase: "Elliott J."
Processing 00000000.tx.8: Mufsonc, and David A. 

Phrase: "Mufsonc,"

Phrase: "and"

Phrase: "David A."
Processing 00000000.tx.9: Bennetta,b,c a Rush Alzheimer's Disease Center, Rush University and Rush PresbyterianSt. 

Phrase: "Bennetta,"

Phrase: "b,c"

Phrase: "a Rush Alzheimer's Disease Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "Rush University"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0443052:Rush [Qualitative Concept]

Phrase: "and"

Phrase: "Rush PresbyterianSt."
Processing 00000000.tx.10: Luke's Medical Center, Chicago, Illinois b Rush Institute for Healthy Aging, Rush University and Rush PresbyterianSt. 

Phrase: "Luke's Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois b Rush Institute for Healthy Aging,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "Rush University"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0443052:Rush [Qualitative Concept]

Phrase: "and"

Phrase: "Rush PresbyterianSt."
Processing 00000000.tx.11: Luke's Medical Center, Chicago, Illinois c Department of Neurological Sciences, Rush University and Rush PresbyterianSt. 

Phrase: "Luke's Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois c Department of Neurological Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Rush University"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0443052:Rush [Qualitative Concept]

Phrase: "and"

Phrase: "Rush PresbyterianSt."
Processing 00000000.tx.12: Luke's Medical Center, Chicago, Illinois Correspondence to: Julie A. 

Phrase: "Luke's Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Julie A."
Processing 00000000.tx.13: Schneider, 1645 W. 

Phrase: "Schneider,"

Phrase: "1645 W."
Processing 00000000.tx.14: Jackson Blvd., Suite 675, Chicago, IL 60612. 

Phrase: "Jackson Blvd.,"

Phrase: "Suite 675,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553446:Suite [Intellectual Product]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL 60612."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.15: E-mail: jschneid@rush.edu Summary Top Summary Introduction Materials and Methods Results Discussion Literature Cited The role of substantia nigra pathology in Alzheimer's disease (AD) is uncertain. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "jschneid@rush.edu Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "The role of substantia nigra pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "uncertain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087130:Uncertain [Idea or Concept]
Processing 00000000.tx.16: Detection of pathology may be obscured by intraneuronal neuromelanin and influenced by stains. 

Phrase: "Detection of pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "obscured by intraneuronal neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0068608:neuromelanin [Organic Chemical]

Phrase: "and"

Phrase: "influenced by stains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.17: We determined methods for optimal visualization of nigral pathology in 45 cases of AD. 

Phrase: "We"

Phrase: "determined"

Phrase: "methods for optimal visualization of nigral pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]

Phrase: "in 45 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of AD."
Processing 00000000.tx.18: For detection of Lewy bodies (LBs), we compared ubiquitin and -synuclein immunostains to hematoxylin and eosin (H&E). 

Phrase: "For detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of Lewy bodies (LBs),"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein immunostains to hematoxylin and eosin (H&E)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.19: For neurofibrillary tangles (NFTs) and neuropil threads (NTs), we compared Gallyas silver and paired helical filament (PHF) immunostains, after bleaching of melanin, to modified Bielschowsky, Gallyas, and PHF alone. 

Phrase: "For neurofibrillary tangles (NFTs)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "neuropil threads (NTs),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "Gallyas silver"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0037125:Silver [Element, Ion, or Isotope]
   861   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   861   C1305285:Silver [Qualitative Concept]
   861   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   777 E C0079853:Moon [Geographic Area]
   768 E C0003782:Argyria [Injury or Poisoning]
   768 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "paired helical filament (PHF) immunostains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: "after"

Phrase: "bleaching of melanin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0303749:bleaching [Inorganic Chemical]

Phrase: "to modified Bielschowsky,"

Phrase: "Gallyas,"

Phrase: "and"

Phrase: "PHF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.20: The number of LB cases was not different using the three stains. 

Phrase: "The number of LB cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "not different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the three stains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.21: However, more LBs per section were detected using -synuclein (z=4.88, p<0.001). 

Phrase: "However,"

Phrase: "more LBs per section"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0085200:Lewy Bodies [Cell Component]
   760   C0242821:bodies [Human]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(z=4.88,"

Phrase: "p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.22: Twice the number of cases exhibited NFT (z=8.21; p<0.001) and the mean NFT number per section was 2.85.2-fold greater, using Gallyas and PHF after bleaching compared to without bleaching (2=142.17; p<0.001). 

Phrase: "Twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: "the number of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "NFT (z=8.21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0085400:NFT [Acquired Abnormality]

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "the mean NFT number per section"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "2.85.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332462:Fold [Spatial Concept]
   812   C1880834:FOLD [Phenomenon or Process]

Phrase: "greater,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0443228:greater [Quantitative Concept]
  1000   C1704243:Greater [Quantitative Concept]
   966 E C0549177:Great [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gallyas"

Phrase: "and"

Phrase: "PHF after bleaching"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   760   C0010851:Filament [Cell Component]
   760   C1709450:Paired [Qualitative Concept]

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "to without bleaching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0303749:bleaching [Inorganic Chemical]
   790   C1883351:To [Qualitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "=142.17"

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.23: More NTs (z=6.54; p<0.001) were observed with PHF and Gallyas after bleaching. 

Phrase: "More NTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0521175:Neuropil Threads [Acquired Abnormality]
   793   C1710394:Thread [Manufactured Object]
   793   C1882475:Thread [Intellectual Product]

Phrase: "(z=6.54"

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "observed with PHF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   760   C0010851:Filament [Cell Component]
   760   C1441672:Observed [Functional Concept]
   760   C1709450:Paired [Qualitative Concept]

Phrase: "and"

Phrase: "Gallyas after bleaching."
Processing 00000000.tx.24: With optimal methods, we found LBs in 27%, NFTs in 89%, and NTs in all 45 AD cases. 

Phrase: "With optimal methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "LBs in 27%,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "NFTs in 89%,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "NTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   861   C0228081:Neuropil [Cell Component]

Phrase: "in all 45 AD cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.25: We show that detection of nigra pathology is influenced by histological method. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that detection of nigra pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "influenced by histological method."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025663:Method [Intellectual Product]
   770   C0205462:Histological [Functional Concept]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.26: Clinicopathological studies using these methods are needed to determine the role of nigral pathology in AD. 

Phrase: "Clinicopathological studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the role of nigral pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in AD."
Processing 00000000.tx.27: (J Histochem Cytochem 50:99106, 2002) Key Words: substantia nigra, neurofibrillary tangles, neuropil threads, Lewy body, Alzheimer's disease, neuromelanin Introduction Top Summary Introduction Materials and Methods Results Discussion Literature Cited Cytoskeletal changes are commonly observed in the substantia nigra (SN) of persons who die of Alzheimer's disease (AD) (Gibb et al. 1989 ; Braak and Braak 1991 ; Kazee et al. 1995 ; Lowe et al. 1997 ). 

Phrase: "(J Histochem Cytochem 50"

Phrase: ":"

Phrase: "99106,"

Phrase: "2002"

Phrase: ")"

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "neuropil threads,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "Lewy body,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085200:Lewy Body [Cell Component]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "neuromelanin Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Cytoskeletal changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "commonly"

Phrase: "observed in the substantia nigra (SN) of persons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   778   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   748   C0027361:Persons [Population Group]
   748   C1441672:Observed [Functional Concept]
   714 E C2347489:Person [Group]

Phrase: "who"

Phrase: "die of Alzheimer's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715   C0011065:Expired [Organism Function]
   715   C0231800:Expired [Organ or Tissue Function]
   715   C1704631:Expire [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) (Gibb et al. 1989"

Phrase: "; Braak"

Phrase: "and"

Phrase: "Braak 1991"

Phrase: "; Kazee et al. 1995"

Phrase: "; Lowe et al. 1997"

Phrase: ")."
Processing 00000000.tx.28: Studies attempting to link these changes to clinical features of the disease have been inconsistent (Leverenz and Sumi 1986 ; Mirra et al. 1991 ; Hulette et al. 1995 ; Kazee et al. 1995 ). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "attempting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "these changes to clinical features of the disease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "inconsistent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442809:Inconsistent [Qualitative Concept]

Phrase: "(Leverenz"

Phrase: "and"

Phrase: "Sumi 1986"

Phrase: "; Mirra et al. 1991"

Phrase: "; Hulette et al. 1995"

Phrase: "; Kazee et al. 1995"

Phrase: ")."
Processing 00000000.tx.29: This may be partly due to the variability of histological techniques used to detect the cytoskeletal changes. 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "partly due to the variability of histological techniques"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0019637:Histological Techniques [Laboratory Procedure]
   770   C0678226:Due to [Functional Concept]
           due
   744   C0025664:techniques [Intellectual Product]
   744   C0205462:Histological [Functional Concept]
   744   C0449851:Techniques [Functional Concept]
   744   C2827666:Variability [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the cytoskeletal changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.30: Multiple silver staining and immunohistochemical methods have become available to study the changes in cells affected by AD. 

Phrase: "Multiple silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1293950:Silver Staining [Laboratory Procedure]
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "immunohistochemical methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "have"

Phrase: "become"

Phrase: "available to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0470187:Available [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the changes in cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C0025320:The change [Physiologic Function]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "affected by AD."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.31: In addition, unlike most other brain regions affected by AD changes, the substantia nigra neurons are laden with a pigment, neuromelanin, that may obscure visualization of intraneuronal pathology. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "unlike most"

Phrase: "other brain regions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:brain regions [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "affected by AD changes,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0392747:changes [Functional Concept]
   770   C0392760:Affected [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "the substantia nigra neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   734   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "laden with a pigment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031916:Pigment [Chemical Viewed Functionally]

Phrase: "neuromelanin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0068608:neuromelanin [Organic Chemical]

Phrase: "that"

Phrase: "may"

Phrase: "obscure"

Phrase: "visualization of intraneuronal pathology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175631:Visualization [Mental Process]
   770   C2827662:Visualization [Occupation or Discipline]
Processing 00000000.tx.32: Few studies have addressed the potential benefit of using different immunohistochemical stains (Irizarry et al. 1998 ) and removing the neuromelanin (Uchihara et al. 1995 ) on the elucidation of nigral pathology in AD brains. 

Phrase: "Few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the potential benefit of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0814225:Benefit [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different immunohistochemical stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Irizarry et al. 1998"

Phrase: ")"

Phrase: "and"

Phrase: "removing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0849355:remove [Qualitative Concept]
   966   C1883720:Remove [Activity]
   966   C3244314:remove [Functional Concept]

Phrase: "the neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0068608:neuromelanin [Organic Chemical]

Phrase: "(Uchihara et al. 1995"

Phrase: ")"

Phrase: "on the elucidation"

Phrase: "of nigral pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "in AD brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.33: In this investigation we examined optimal methods for detection of Lewy body (LB) and neurofibrillary pathology in the substantia nigra in 45 cases of AD. 

Phrase: "In this investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1261322:Investigation [Health Care Activity]
  1000   C1552578:investigation [Idea or Concept]
   928 E C1517586:Investigational [Qualitative Concept]
   928 E C3245491:investigational [Intellectual Product]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "optimal methods for detection of Lewy body (LB)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   789   C0449335:Method of detection [Intellectual Product]
           detection methods
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "neurofibrillary pathology in the substantia nigra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]

Phrase: "in 45 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of AD."
Processing 00000000.tx.34: We used several different immunohistochemical stains and pretreated selected tissue sections with the bleaching agent potassium manganese peroxide, which removes cellular neuromelanin (Uchihara et al. 1995 ). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "several different immunohistochemical stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "pretreated"

Phrase: "selected tissue sections with the bleaching agent potassium manganese peroxide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   743   C2316368:Tissue section [Tissue]
   706   C0205155:Section [Spatial Concept]
   706   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   706   C1522472:Section [Substance]
   706   C1552923:Section [Quantitative Concept]
   706   C1705191:Section [Physical Object]

Phrase: "which"

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "cellular neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0068608:neuromelanin [Organic Chemical]

Phrase: "(Uchihara et al. 1995"

Phrase: ")."
Processing 00000000.tx.35: The results of these experiments were blindly compared to results using the more conventional methodologies. 

Phrase: "The results of these experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C2825142:Experimental Result [Finding]
           Result
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]

Phrase: "were"

Phrase: "blindly"

Phrase: "compared to results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1707455:Compared [Activity]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the more conventional methodologies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0969625:methodology [Intellectual Product]
   793   C3266812:Methodology [Idea or Concept]
Processing 00000000.tx.36: Specifically, for detection and counts of LBs, we compared ubiquitin and -synuclein immunostain to hematoxylin and eosin (H&E). 

Phrase: "Specifically,"

Phrase: "for detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "counts of LBs,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C0439157:counts [Quantitative Concept]
   770   C0750480:Count [Activity]
   770   C1705566:Count [Quantitative Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "immunostain to hematoxylin and eosin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "(H&E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.37: For detection and counts of neurofibrillary tangles (NFTs) and neuropil threads (NTs), we compared Gallyas silver stain and paired helical filament (PHF) immunostain, after the application of bleach, to modified Bielschowsky silver and to Gallyas silver stain and PHF without the use of bleach. 

Phrase: "For detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "counts of neurofibrillary tangles"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]
   770   C0439157:counts [Quantitative Concept]
   770   C0750480:Count [Activity]
   770   C1705566:Count [Quantitative Concept]

Phrase: "(NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "(NTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "Gallyas silver stain"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "paired helical filament"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(PHF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: ")"

Phrase: "immunostain,"

Phrase: "after"

Phrase: "the application of bleach,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to modified Bielschowsky silver"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and to Gallyas silver stain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "PHF without the use of bleach."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   744   C0010851:Filament [Cell Component]
   744   C1709450:Paired [Qualitative Concept]
Processing 00000000.tx.38: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion Literature Cited Cases and Neuropathological Evaluation Forty-five cases of AD were obtained from the neuropathology laboratory at the Rush Alzheimer's Disease Center. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature Cited Cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "Neuropathological Evaluation Forty-five cases of AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from the neuropathology laboratory"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   760   C1301820:Obtained [Functional Concept]
   760   C1540677:neuropathology [Pathologic Function]
   760   C1555824:Neuropathology [Intellectual Product]
   760   C3244292:laboratory [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "at the Rush Alzheimer's Disease Center."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]
Processing 00000000.tx.39: Subjects had all presented with dementia and had a clinical diagnosis of dementia that was confirmed as probable or definite AD by neuropathological evaluation (see below). 

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "all"

Phrase: "presented with dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0449450:Presented [Idea or Concept]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "had"

Phrase: "a clinical diagnosis of dementia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "that"

Phrase: "was"

Phrase: "confirmed as probable"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0033204:Probable [Quantitative Concept]
   790   C0332148:Probable [Qualitative Concept]
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "or"

Phrase: "definite AD by neuropathological evaluation"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.40: Records from these cases did not contain uniform assessment for disease severity, extrapyramidal signs, or a diagnosis of dementia with LBs (McKeith et al. 1996 , McKeith et al. 1999 ). 

Phrase: "Records from these cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034869:Records [Intellectual Product]
   770   C1548330:Records [Idea or Concept]
   770   C1553414:Records [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "uniform assessment for disease severity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "extrapyramidal signs,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0234133:Extrapyramidal signs [Sign or Symptom]
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "or"

Phrase: "a diagnosis of dementia with LBs"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0011900:Diagnosis [Finding]
   748   C0242821:bodies [Human]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]
   748   C1704338:diagnosis [Qualitative Concept]
   748   C1704656:DIAGNOSIS [Research Activity]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "(McKeith et al. 1996 ,"

Phrase: "McKeith et al. 1999"

Phrase: ")."
Processing 00000000.tx.41: No subject had a known clinical diagnosis of idiopathic Parkinson's disease. 

Phrase: "No subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "a known clinical diagnosis of idiopathic Parkinson's disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0332140:Diagnosis, clinical [Qualitative Concept]
   744   C0011900:Diagnosis [Finding]
   744   C0205210:Clinical [Qualitative Concept]
   744   C1704338:diagnosis [Qualitative Concept]
   744   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.42: No exclusion criteria were applied. 

Phrase: "No exclusion criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:Exclusion Criteria [Functional Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "applied."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.43: A total of 45 cases (23 female, 22 male) were evaluated with a mean age at death of 78.3 years (SD = 6.89; range 5994). 

Phrase: "A total of 45 cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "(23 female,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015780:Female [Finding]
   861   C0043210:female [Population Group]
   861   C0086287:female [Population Group]
   861   C1705497:Female [Qualitative Concept]
   861   C1705498:Female [Qualitative Concept]

Phrase: "22 male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0024554:Male [Finding]
   861   C0086582:male [Population Group]
   861   C1706180:Male [Qualitative Concept]
   861   C1706428:Male [Qualitative Concept]
   861   C1706429:Male [Organism Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "evaluated with a mean age"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001779:Age [Organism Attribute]
   760   C0220825:Evaluated [Functional Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "at death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "of 78.3 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: "(SD = 6.89"

Phrase: "; range 5994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.44: The brains were removed from the calvaria 224 hr (mean postmortem interval 7.8; SD = 5.5) after death and processed using standard protocols. 

Phrase: "The brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "removed from the calvaria 224 hr (mean postmortem interval 7.8"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   738   C0004398:postmortem [Diagnostic Procedure]
   738   C0205950:Calvaria [Body Part, Organ, or Organ Component]
   738   C0444504:Mean [Quantitative Concept]
   738   C0580205:Postmortem [Temporal Concept]
   738   C0848632:post mortem [Finding]
   738   C0849355:Removed [Qualitative Concept]
   738   C1272706:Interval [Temporal Concept]
   738   C1552654:Interval [Idea or Concept]
   738   C1552713:Interval [Intellectual Product]
   738   C2347634:Mean [Quantitative Concept]
   738   C2348143:Mean [Quantitative Concept]
   704 E C1883720:Remove [Activity]
   704 E C3244314:remove [Functional Concept]

Phrase: "; SD = 5.5"

Phrase: ")"

Phrase: "after"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.45: The brainstem was removed at the level of the diencephalicmesencephalic junction and the hemispheres cut into 1-cm coronal slabs. 

Phrase: "The brainstem"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "removed at the level of the diencephalicmesencephalic junction"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0205144:Junction [Spatial Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C0849355:Removed [Qualitative Concept]
   744   C1547707:Level [Geographic Area]
   744   C1706311:Junction [Medical Device]
   744   C2946261:Level [Pharmacologic Substance]
   711 E C1883720:Remove [Activity]
   711 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the hemispheres"

Phrase: "cut into 1-cm coronal slabs."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0000925:Cut [Injury or Poisoning]
   753   C0183335:slabs [Medical Device]
   753   C0205123:Coronal [Spatial Concept]
   753   C1883724:CUT [Phenomenon or Process]
Processing 00000000.tx.46: The brainstem and slabs were then fixed in 4% paraformaldehyde for up to 7 days. 

Phrase: "The brainstem"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "slabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183335:slabs [Medical Device]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "fixed in 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for"

Phrase: "up to 7 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547085:7 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.47: Multiple cortical regions of brain (including midfrontal, superior temporal, inferior parietal cortices, and hippocampus) were embedded in paraffin, cut into 6-m sections, mounted on slides, and stained with H&E and modified Bielschowsky silver stain or thioflavin S stain (Mufson et al. 1988 ). 

Phrase: "Multiple cortical regions of brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1273723:brain regions [Body Location or Region]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "midfrontal, superior temporal, inferior parietal cortices,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   841   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   799   C0442030:Parietal [Spatial Concept]
   799   C0542339:Inferior [Spatial Concept]
   799   C0678975:inferior [Social Behavior]
   793   C0030560:Parietal cortex [Body Part, Organ, or Organ Component]
   766   C0007776:Cortex [Body Part, Organ, or Organ Component]
   766   C1176472:Cortex [Body Part, Organ, or Organ Component]
   766   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "were"

Phrase: "embedded in paraffin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]

Phrase: "cut into 6-m sections,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0000925:Cut [Injury or Poisoning]
   760   C1883724:CUT [Phenomenon or Process]

Phrase: "mounted on slides,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444330:slides [Research Device]
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]
   756 E C1705201:Slide [Manufactured Object]

Phrase: "and"

Phrase: "stained with H&E"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   891   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   781   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "modified Bielschowsky silver stain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1293957:Bielschowsky's silver stain [Laboratory Procedure]
           Bielschowsky's stain
   861   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
   812   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "thioflavin S stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Mufson et al. 1988"

Phrase: ")."
Processing 00000000.tx.48: Neuropathological diagnoses of AD were rendered using the protocol developed by the Consortium to Establish a Registry of Alzheimer's disease (Mirra et al. 1991 ). 

Phrase: "Neuropathological diagnoses of AD"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0011900:Diagnoses [Finding]
   737 E C1704338:diagnosis [Qualitative Concept]
   737 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "were"

Phrase: "rendered"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "developed by the Consortium to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1513822:Consortium [Professional or Occupational Group]
   760   C1880171:Consortium [Professional or Occupational Group]

Phrase: "Establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a Registry of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0920465:disease registry [Intellectual Product]
   760   C0034975:Registry [Intellectual Product]

Phrase: "(Mirra et al. 1991"

Phrase: ")."
Processing 00000000.tx.49: Evaluation of the Substantia Nigra Consecutive 6-m sections of midbrain, including the substantia nigra, were cut from the available paraffin-embedded block at approximately the level of exit of the third nerve. 

Phrase: "Evaluation of the Substantia Nigra Consecutive 6-m sections of midbrain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0220825:Evaluation [Functional Concept]
   738   C1261322:Evaluation [Health Care Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "cut from the available paraffin-embedded block"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   774   C0085185:embedded paraffin [Laboratory Procedure]
   748   C0000925:Cut [Injury or Poisoning]
   748   C0028778:Block [Pathologic Function]
   748   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   748   C0332206:Block [Functional Concept]
   748   C0470187:Available [Functional Concept]
   748   C1533157:Block [Substance]
   748   C1706084:Block [Geographic Area]
   748   C1707903:Embedded [Laboratory Procedure]
   748   C1883724:CUT [Phenomenon or Process]
   748   C2828370:Block [Quantitative Concept]

Phrase: "at approximately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332232:Approximately [Qualitative Concept]

Phrase: "the level of exit of the third nerve."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.50: We applied eight methods of staining to adjacent sections of substantia nigra, including H&E stain, modified Bielschowsky silver stain (Mufson et al. 1988 ), Gallyas silver stain (Gallyas 1971 ; Kobayashi et al. 1992 ), immunohistochemistry with antibodies to PHF [PHF-1, identifying a modification of the tau protein (Greenberg et al. 1992 ), 1:1000], ubiquitin (East Acres Biologicals, Southbridge, MA; 

Phrase: "We"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "eight methods of staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C0487602:methods staining [Laboratory Procedure]
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "to adjacent sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "of substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "H&E stain,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0523207:Haematoxylin and eosin stain [Laboratory Procedure]
   902   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   812   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   812   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "modified Bielschowsky silver stain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1293957:Bielschowsky's silver stain [Laboratory Procedure]
           Bielschowsky's stain
   861   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
   812   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Mufson et al. 1988"

Phrase: ")"

Phrase: ","

Phrase: "Gallyas silver stain"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "(Gallyas 1971"

Phrase: "; Kobayashi et al. 1992"

Phrase: ")"

Phrase: ","

Phrase: "immunohistochemistry with antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "to PHF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "[PHF-1,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   812   C0010851:Filament [Cell Component]
   812   C1709450:Paired [Qualitative Concept]
   741 E C1979891:Filamentous [Qualitative Concept]

Phrase: "identifying"

Phrase: "a modification of the tau protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0033666:Protein Modification [Molecular Function]
   783   C2263112:protein modification [Molecular Function]
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "(Greenberg et al. 1992"

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: "],"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(East Acres Biologicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2979985:Biologicals [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Southbridge,"

Phrase: "MA"

Phrase: ";"
Processing 00000000.tx.51: 1:30,000) and -synuclein (Chemicon International, Temecula, CA; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "30,000"

Phrase: ")"

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555271:Temecula [Population Group]

Phrase: "CA"

Phrase: ";"
Processing 00000000.tx.52: 1:3750); 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "3750"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.53: and Gallyas silver stain and PHF-1 immunostain after applying bleach to tissue sections to remove neuromelanin (Uchihara et al. 1995 ). 

Phrase: "and"

Phrase: "Gallyas silver stain"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "PHF-1 immunostain after applying bleach"

Phrase: "to tissue sections to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C2316368:Tissue section [Tissue]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0068608:neuromelanin [Organic Chemical]

Phrase: "(Uchihara et al. 1995"

Phrase: ")."
Processing 00000000.tx.54: All sections were mounted on electrostatically charged plus slides (Daigger and Co.; Lincolnshire, IL), dehydrated in alcohols and xylene, and coverslipped with Permount. 

Phrase: "All sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted on electrostatically"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]

Phrase: "charged plus slides"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0332287:Plus [Qualitative Concept]
   790   C0444330:slides [Research Device]
   790   C1706211:Charged [Organism Attribute]
   756 E C0007961:Charge [Quantitative Concept]
   756 E C1705201:Slide [Manufactured Object]

Phrase: "(Daigger"

Phrase: "and"

Phrase: "Co."

Phrase: "; Lincolnshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454864:Lincolnshire [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "dehydrated in alcohols"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   841   C2825044:Dehydrated Alcohol [Organic Chemical,Pharmacologic Substance]
   790   C0001975:Alcohols [Organic Chemical,Pharmacologic Substance]
   790   C0011175:Dehydrated [Disease or Syndrome]
   756 E C0001962:ALCOHOL [Organic Chemical]
   706 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "and"

Phrase: "xylene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "coverslipped with Permount."
Processing 00000000.tx.55: Gallyas silver staining was performed as originally described (Gallyas 1971 ) with the additional application of Schiff's reagent and counterstaining with hematoxylin after physical development, similar to the modified Gallyas technique or GallyasSchiff stain (Kobayashi et al. 1992 ) but without the pretreatment with periodic acid solution. 

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "was"

Phrase: "performed as originally"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Gallyas 1971"

Phrase: ")"

Phrase: "with the additional application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0185125:Application [Health Care Activity]
   861   C1947919:Application [Intellectual Product]
   861   C2347934:Application [Intellectual Product]
   861   C3539080:APPLICATION [Quantitative Concept]

Phrase: "of Schiff's reagent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1130433:Schiff's reagent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   861   C2949227:Schiff [Pharmacologic Substance]

Phrase: "and"

Phrase: "counterstaining with hematoxylin"

Phrase: "after physical development,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0871079:physical development [Natural Phenomenon or Process]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "similar to the modified Gallyas technique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "GallyasSchiff stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Kobayashi et al. 1992"

Phrase: ")"

Phrase: "but without the pretreatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "with periodic acid solution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]
   734   C0031068:Periodic Acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.56: PHF, ubiquitin, and -synuclein immunostains were performed using the avidinbiotinperoxidase method (ABC Elite; Vector, Burlingame, CA). 

Phrase: "PHF,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein immunostains"

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the avidinbiotinperoxidase method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(ABC Elite"

Phrase: "; Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA)."
Processing 00000000.tx.57: Briefly, paraffin-embedded tissues were mounted on electrostatically charged slides, deparaffinized, washed, and blocked with normal serum. 

Phrase: "Briefly,"

Phrase: "paraffin-embedded tissues"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C1519524:Paraffin Embedded Tissue [Tissue]
           Tissue, Paraffin
   827   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   827   C0040300:Tissues [Tissue]
   827   C1707903:Embedded [Laboratory Procedure]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "mounted on electrostatically charged slides,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0444330:slides [Research Device]
   760   C0449878:mounted [Finding]
   760   C1706211:Charged [Organism Attribute]
   726 E C0181909:Mount [Medical Device]
   726 E C1705201:Slide [Manufactured Object]

Phrase: "deparaffinized"

Phrase: ","

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "blocked with normal serum."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0028778:Blocked [Pathologic Function]
   770   C0205307:Normal [Qualitative Concept]
   770   C0229671:Serum [Body Substance]
   770   C0332206:Blocked [Functional Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C2347086:% Normal [Quantitative Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.58: Sections were then incubated with the primary antibody overnight, washed, incubated with the biotinylated secondary antibody for 1 hr, and then with the avidinbiotinperoxidase complex for 30 min. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with the primary antibody overnight,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439583:Overnight [Temporal Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "incubated with the biotinylated secondary antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1 hr,"

Phrase: "and"

Phrase: "then with the avidinbiotinperoxidase complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1883708:Then [Temporal Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.59: The chromogen for color development was 3,3'diaminobenzidine. 

Phrase: "The chromogen for color development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0052799:Chromogen [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3'diaminobenzidine."
Processing 00000000.tx.60: Immunohistochemical controls consisted of sections incubated without primary antibody. 

Phrase: "Immunohistochemical controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "consisted of sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0205155:Section [Spatial Concept]
   756   C0332529:CONSIST [Qualitative Concept]
   756   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   756   C1522472:Section [Substance]
   756   C1552923:Section [Quantitative Concept]
   756   C1705191:Section [Physical Object]

Phrase: "incubated without primary antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.61: Positive controls included neocortical tissue from known cases of AD (for PHF immunostaining) and LB disease (ubiquitin and -synuclein immunostaining). 

Phrase: "Positive controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   966   C1883676:Positive Control [Conceptual Entity]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "neocortical tissue from known cases of AD ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040300:Tissue [Tissue]
   748   C1547928:Tissue [Intellectual Product]

Phrase: "for PHF immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "and"

Phrase: "LB disease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0752347:Lewy Body Disease [Disease or Syndrome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   743 E C1995017:Bodies [Cell Component]

Phrase: "(ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein immunostaining"

Phrase: ")."
Processing 00000000.tx.62: Bleaching of the tissue sections for removal of neuromelanin was performed before immunohistochemistry with PHF and Gallyas silver staining (see above). 

Phrase: "Bleaching of the tissue sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0303749:bleaching [Inorganic Chemical]

Phrase: "for removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0068608:neuromelanin [Organic Chemical]

Phrase: "was"

Phrase: "performed before immunohistochemistry"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with PHF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "and"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.63: The bleaching procedure was accomplished by 30-min incubation of mounted tissue sections in 0.25% potassium manganese peroxide followed by a 5-min incubation in 5% oxalic acid, as previously described (Uchihara et al. 1995 ). 

Phrase: "The bleaching procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "accomplished by 30-min incubation of mounted tissue sections"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C0456693:/30 min [Temporal Concept]
   764   C1442458:30 min [Temporal Concept]
   748   C2316368:Tissue section [Tissue]
   742   C0040300:Tissue [Tissue]
   742   C0449878:mounted [Finding]
   742   C0702093:/min [Temporal Concept]
   742   C1547928:Tissue [Intellectual Product]
   708 E C0181909:Mount [Medical Device]
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1522472:Section [Substance]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]

Phrase: "in 0.25% potassium manganese peroxide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0384948:potassium manganese peroxide [Inorganic Chemical]
   804   C0031180:Peroxide [Inorganic Chemical]

Phrase: "followed by a 5-min incubation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0702093:/min [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "in 5% oxalic acid,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0069715:Oxalic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   901   C0600422:oxalic acid [Organic Chemical]
   901   C1144584:oxalic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Uchihara et al. 1995"

Phrase: ")."
Processing 00000000.tx.64: Immunohistochemistry was performed in groups of 10 and identically after bleaching as in cases where bleaching was not performed. 

Phrase: "Immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed in groups of 10"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C0884358:Performed [Functional Concept]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "identically after bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0303749:bleaching [Inorganic Chemical]

Phrase: "as in cases where bleaching"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0303749:bleaching [Inorganic Chemical]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.65: For the Gallyas silver staining, length of time in the developer differed in those cases with and without bleach. 

Phrase: "For the Gallyas silver staining,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "length of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1444754:Length [Quantitative Concept]
   790   C1706316:LENGTH [Research Activity]
   718 E C0205166:Long [Qualitative Concept]
   718 E C1522425:Longest [Qualitative Concept]
   718 E C1706317:Long [Qualitative Concept]

Phrase: "in the developer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2363670:developer [Medical Device]

Phrase: "differed in those cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "with"

Phrase: "and without bleach."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0303749:Bleach [Inorganic Chemical]
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.66: After bleaching the length of time in the developer was generally longer, typically 10 min or until sections turned light brown, whereas without bleaching the length of time in the developer was typically 8 min for optimal staining of nigral NFTs and NTs. 

Phrase: "After"

Phrase: "bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleaching [Inorganic Chemical]

Phrase: "the length of time"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444754:Length [Quantitative Concept]
   770   C1706316:LENGTH [Research Activity]

Phrase: "in the developer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2363670:developer [Medical Device]

Phrase: "was"

Phrase: "generally longer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205166:Long [Qualitative Concept]
   827   C1706317:Long [Qualitative Concept]

Phrase: "typically 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "or until sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0205155:Section [Spatial Concept]
   756   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   756   C1522472:Section [Substance]
   756   C1552923:Section [Quantitative Concept]
   756   C1705191:Section [Physical Object]

Phrase: "turned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0541749:turned [Finding]
   966 E C1709743:Turn [Spatial Concept]

Phrase: "light brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "whereas without bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0303749:bleaching [Inorganic Chemical]

Phrase: "the length of time"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444754:Length [Quantitative Concept]
   770   C1706316:LENGTH [Research Activity]

Phrase: "in the developer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2363670:developer [Medical Device]

Phrase: "was"

Phrase: "typically 8 min for optimal staining of nigral NFTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "NTs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.67: Preliminary experiments showed that bleaching before the modified Bielschowsky procedure did not enhance visualization of neuritic pathology compared to the Gallyas and PHF stains after bleaching (data not shown). 

Phrase: "Preliminary experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that bleaching before the modified Bielschowsky procedure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0303749:bleaching [Inorganic Chemical]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "visualization of neuritic pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175631:Visualization [Mental Process]
   770   C2827662:Visualization [Occupation or Discipline]

Phrase: "compared to the Gallyas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "PHF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "stains after bleaching"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C1293959:Bleach stain [Laboratory Procedure]
   790   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   790   C0303749:bleaching [Inorganic Chemical]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.68: Therefore, bleaching was not used before modified Bielschowsky. 

Phrase: "Therefore,"

Phrase: "bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleaching [Inorganic Chemical]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "used before modified Bielschowsky."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0392747:Modified [Functional Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.69: The bleaching technique was also attempted before ubiquitin and -synuclein immunostaining. 

Phrase: "The bleaching technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449851:Technique [Functional Concept]
   777 E C0025664:techniques [Intellectual Product]

Phrase: "was"

Phrase: "also"

Phrase: "attempted before ubiquitin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1516084:Attempt [Event]

Phrase: "and -"

Phrase: "synuclein immunostaining."
Processing 00000000.tx.70: However, these antibodies stained the neuromelanin granules in addition to the inclusions (LBs), rendering no appreciable detection advantage in the use of bleach (personal observations). 

Phrase: "However,"

Phrase: "these antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "the neuromelanin granules in addition to the inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0010837:Granules [Cell Component]
   744   C0993609:Granules [Biomedical or Dental Material]

Phrase: "(LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ")"

Phrase: ","

Phrase: "rendering"

Phrase: "no appreciable detection advantage in the use of bleach"

Phrase: "(personal observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.71: Rating of Pathology in the Substantia Nigra The same examiner (JAS) scored all 45 cases. 

Phrase: "Rating of Pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0871208:Rating [Activity]

Phrase: "in the Substantia Nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "The same examiner"

Phrase: "(JAS"

Phrase: ")"

Phrase: "scored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:scored [Quantitative Concept]

Phrase: "all 45 cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.72: Cases were separated into two batteries of stains and the examiner was blinded to the results of the initial battery when examining the second battery. 

Phrase: "Cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "separated into two batteries of stains"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
   753   C0086972:Separated [Finding]
   753   C0205448:Two [Quantitative Concept]
   753   C0337088:batteries [Manufactured Object]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   719 E C0542351:Battery [Injury or Poisoning]

Phrase: "and"

Phrase: "the examiner"

Phrase: "was"

Phrase: "blinded to the results of the initial battery"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   744   C0150108:Blinded [Research Activity]
   744   C0205265:Initial [Temporal Concept]
   744   C0337088:battery [Manufactured Object]
   744   C0542351:Battery [Injury or Poisoning]
   744   C1279901:Initial [Qualitative Concept]
   744   C1555582:Initial [Idea or Concept]
   744   C1705685:INITIAL [Functional Concept]
   711 E C0456909:Blind [Disease or Syndrome]
   711 E C0525065:blind [Patient or Disabled Group]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "when"

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "the second battery."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337088:battery [Manufactured Object]
   861   C0542351:Battery [Injury or Poisoning]
Processing 00000000.tx.73: The initial battery of stains included H&E for LBs, Bielschowsky silver staining, Gallyas silver staining, and PHF immunostaining for NFTs, and Gallyas silver staining and PHF immunostaining for NTs. 

Phrase: "The initial battery of stains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0337088:battery [Manufactured Object]
   760   C0542351:Battery [Injury or Poisoning]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "H&E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "for LBs,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "Bielschowsky silver staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1293950:Silver Staining [Laboratory Procedure]
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "Gallyas silver staining,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "PHF immunostaining for NFTs,"

Phrase: "and"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "PHF immunostaining for NTs."
Processing 00000000.tx.74: Bielschowsky silver staining was not used to assess NTs because the dense staining of axonal elements and vessels interfered with the evaluation of NTs. 

Phrase: "Bielschowsky silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1293950:Silver Staining [Laboratory Procedure]
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "NTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "because"

Phrase: "the dense staining of axonal elements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "interfered with the evaluation of NTs."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0521175:Neuropil Threads [Acquired Abnormality]
   748   C0220825:Evaluation [Functional Concept]
   748   C0228081:Neuropil [Cell Component]
   748   C0521102:Interfered [Qualitative Concept]
   748   C1261322:Evaluation [Health Care Activity]
   714   C1710394:Thread [Manufactured Object]
   714   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.75: The second battery of stains included ubiquitin and -synuclein immunostaining for LBs and Gallyas silver staining and PHF immunostaining after applying bleach for removal of neuromelanin for NFTs and NTs. 

Phrase: "The second battery of stains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0337088:battery [Manufactured Object]
   760   C0542351:Battery [Injury or Poisoning]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein immunostaining for LBs"

Phrase: "and"

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "PHF immunostaining after applying bleach"

Phrase: "for removal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "of neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0068608:neuromelanin [Organic Chemical]

Phrase: "for NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "NTs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.76: The total numbers of NFTs and LBs in the 6-m hemisection were counted using a microscopic field at a magnification of x100. 

Phrase: "The total numbers of NFTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0237753:*Number [Quantitative Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "LBs in the 6-m hemisection"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0242821:bodies [Human]
   748   C1995017:Bodies [Cell Component]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microscopic field at a magnification of x100."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   744   C1521738:Field [Conceptual Entity]
   744   C2346620:Field [Conceptual Entity]
   744   C2349184:Field [Conceptual Entity]
   744   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.77: We counted all positive structures within each frame from medial to lateral. 

Phrase: "We"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "all positive structures within each frame"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "from medial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205098:Medial [Spatial Concept]

Phrase: "to lateral."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205093:Lateral [Spatial Concept]
Processing 00000000.tx.78: We found that we were able to obtain reliable counts without the aid of a grid. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "reliable counts without the aid of a grid."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0439157:counts [Quantitative Concept]
   711 E C0750480:Count [Activity]
   711 E C1705566:Count [Quantitative Concept]
Processing 00000000.tx.79: The slide was manually moved across the stage in a stepwise manner, to avoid redundancy in counting, until all positive structures were counted. 

Phrase: "The slide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444330:Slide [Research Device]
  1000   C1705201:Slide [Manufactured Object]

Phrase: "was"

Phrase: "manually"

Phrase: "moved across the stage"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205390:Stage [Temporal Concept]
   770   C1269909:moved [Functional Concept]
   770   C1299988:moved [Functional Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   770   C2699029:Moved [Activity]
   737 E C0560560:move [Organism Function]
   737 E C0578671:move [Finding]

Phrase: "in a stepwise manner,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "redundancy in counting,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1313915:Redundancy [Functional Concept]
   718 E C0425087:Redundant [Finding]

Phrase: "until"

Phrase: "all positive structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "counted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.80: A magnification of x200 was used when clarification was needed for structural identification (see below). 

Phrase: "A magnification of x200"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "when"

Phrase: "clarification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarification [Activity]

Phrase: "was"

Phrase: "needed for structural identification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020792:Identification [Mental Process]
   770   C0027552:Needed [Qualitative Concept]
   770   C0205396:Identification [Qualitative Concept]
   770   C0678594:Structural [Spatial Concept]
   770   C0686904:needed [Functional Concept]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.81: The section was first visually scanned at low power to delineate the region of the substantia nigra and note was made if the section was incomplete or was significantly distant from the region of the third nerve exit. 

Phrase: "The section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "first visually"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "scanned at low power to"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0032863:Power [Human-caused Phenomenon or Process]
   760   C0205251:low [Qualitative Concept]
   760   C0441633:scanned [Diagnostic Procedure]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0034606:Scan [Diagnostic Procedure]
   726 E C2826292:SCAN [Finding]

Phrase: "delineate"

Phrase: "the region of the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "was"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "if"

Phrase: "the section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "incomplete"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205257:Incomplete [Quantitative Concept]
  1000   C0728938:incomplete [Quantitative Concept]
  1000   C1548386:incomplete [Idea or Concept]

Phrase: "or"

Phrase: "was"

Phrase: "significantly distant from the region of the third nerve exit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0443203:Distant [Spatial Concept]
Processing 00000000.tx.82: Quantitation of NFTs and LBs was completed on each slide from a medial to lateral direction. 

Phrase: "Quantitation of NFTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "and"

Phrase: "LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "was"

Phrase: "completed on each slide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205197:COMPLETED [Qualitative Concept]
   770   C0444330:Slide [Research Device]
   770   C1705201:Slide [Manufactured Object]

Phrase: "from a medial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205098:Medial [Spatial Concept]

Phrase: "to lateral direction."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0449738:Direction [Spatial Concept]
   761 E C1707761:Directionality [Functional Concept]
   761 E C3274524:Directionality [Functional Concept]
Processing 00000000.tx.83: NFTs were identified when there was positive intraneuronal staining (brownish black on Bielschowsky, Gallyas, and PHF immunostaining; black with bleaching before Gallyas and PHF immunostaining) and a fibrillar morphology. 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "when"

Phrase: "there"

Phrase: "was"

Phrase: "positive intraneuronal staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(brownish black on Bielschowsky,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0439541:Black [Qualitative Concept]

Phrase: "Gallyas,"

Phrase: "and"

Phrase: "PHF immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: "; black with bleaching"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0005680:Black [Population Group]
   790   C0027567:Black [Population Group]
   790   C0085756:Black [Population Group]
   790   C0439541:Black [Qualitative Concept]

Phrase: "before Gallyas"

Phrase: "and"

Phrase: "PHF immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "and"

Phrase: "a fibrillar morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.84: Identification of LBs required a neuronal intracytoplasmic rounded structure (pinkish-red on H&E or brown on immunostaining), typically with a peripheral halo. 

Phrase: "Identification of LBs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0277767:Body identification [Finding]
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "a neuronal intracytoplasmic rounded structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0682678:neuron structure [Cell Component]
   812   C0678594:Structure [Spatial Concept]

Phrase: "(pinkish-red on H&E"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0332575:Red [Finding]
   753   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   753   C1260956:Red [Qualitative Concept]

Phrase: "or"

Phrase: "brown on immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678579:Brown [Natural Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "typically with a peripheral halo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205100:Peripheral [Spatial Concept]
   760   C0271188:HALO [Sign or Symptom]
   760   C3541466:halo [Cell Component]
Processing 00000000.tx.85: Because LBs immunostained with ubiquitin and -synuclein do not always show halos (McKeith et al. 1996 , McKeith et al. 1999 ), we also counted the stained structure as an LB if it was intraneuronal, round, and well circumscribed but showed no definite halo. 

Phrase: "Because"

Phrase: "LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "immunostained with ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "do"

Phrase: "not always"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C2003902:Always [Temporal Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "halos"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0271188:HALO [Sign or Symptom]
   966   C3541466:halo [Cell Component]

Phrase: "(McKeith et al. 1996 ,"

Phrase: "McKeith et al. 1999"

Phrase: ")"

Phrase: ","

Phrase: "we also"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "the stained structure as an LB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0229962:Body Structure [Body Part, Organ, or Organ Component]
   774   C1268086:Body structure [Anatomical Structure]
   748   C0678594:Structure [Spatial Concept]

Phrase: "if"

Phrase: "it"

Phrase: "was"

Phrase: "intraneuronal, round,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332490:Round [Spatial Concept]

Phrase: "and"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "circumscribed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282914:Circumscribed [Spatial Concept]
  1000   C2347775:Circumscribed [Activity]

Phrase: "but"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no definite halo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0271188:HALO [Sign or Symptom]
   861   C3541466:halo [Cell Component]
Processing 00000000.tx.86: Only structures that fulfilled the above criteria were included in the counts. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "that"

Phrase: "fulfilled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Fulfill [Idea or Concept]

Phrase: "the above criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "included in the counts."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332257:included [Functional Concept]
   770   C0439157:counts [Quantitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C0750480:Count [Activity]
   737 E C1552866:include [Idea or Concept]
   737 E C1705566:Count [Quantitative Concept]
   737 E C2700399:Include [Activity]
Processing 00000000.tx.87: Neuropil threads (NTs) were scored in the region of substantia nigra exhibiting the greatest density within the hemisection. 

Phrase: "Neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "(NTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "scored in the region of substantia nigra"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   778   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C0449820:scored [Quantitative Concept]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "the greatest density within the hemisection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]
Processing 00000000.tx.88: The slide was first scanned at low power to determine the location of greatest density of NTs within the substantia nigra and then scored on a semiquantitative scale, from 0 (none) to 5 (severe) at a total magnification of x200. 

Phrase: "The slide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444330:Slide [Research Device]
  1000   C1705201:Slide [Manufactured Object]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "scanned at low power to"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0032863:Power [Human-caused Phenomenon or Process]
   760   C0205251:low [Qualitative Concept]
   760   C0441633:scanned [Diagnostic Procedure]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0034606:Scan [Diagnostic Procedure]
   726 E C2826292:SCAN [Finding]

Phrase: "determine"

Phrase: "the location of greatest density of NTs"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0521175:Neuropil Threads [Acquired Abnormality]
   744   C0178587:density [Quantitative Concept]
   744   C0205393:Greatest [Quantitative Concept]
   744   C0228081:Neuropil [Cell Component]
   744   C0450429:Location [Spatial Concept]
   744   C1515974:Location [Body Location or Region]
   744   C1710394:Thread [Manufactured Object]
   744   C1882475:Thread [Intellectual Product]
   711 E C0549177:Great [Quantitative Concept]
   711 E C1704243:Great [Quantitative Concept]

Phrase: "within the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "scored on a semiquantitative scale,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0175659:Scale [Medical Device]
   760   C0349674:Scale [Intellectual Product]
   760   C0449820:scored [Quantitative Concept]
   760   C1947916:Scale [Activity]
   760   C3536777:Scale [Manufactured Object]

Phrase: "from 0"

Phrase: "("

Phrase: "none"

Phrase: ")"

Phrase: "to 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(severe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severe [Qualitative Concept]

Phrase: ")"

Phrase: "at a total magnification"

Phrase: "of x200."
Processing 00000000.tx.89: A score of 1 = rare NTs or <5 NTs/high-power field (hpf); 

Phrase: "A score of 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449820:Score [Quantitative Concept]

Phrase: "= rare NTs or <5 NTs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0521175:Neuropil Threads [Acquired Abnormality]
   795   C0228081:Neuropil [Cell Component]
   795   C0521114:Rare [Temporal Concept]
   795   C0522498:Rare [Qualitative Concept]
   795   C1514917:RARE [Gene or Genome]
   762   C1710394:Thread [Manufactured Object]
   762   C1882475:Thread [Intellectual Product]

Phrase: "/high-power field (hpf)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1552990:High Power Field [Quantitative Concept]
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1299351:High [Qualitative Concept]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C2700149:HIGH [Intellectual Product]
   827   C3539073:FIELD [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.90: a score of 2 = slight or about 615 NTs/hpf; 

Phrase: "a score of 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449820:Score [Quantitative Concept]

Phrase: "= slight"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2937276:Slight [Qualitative Concept]
  1000   C2945599:Slight [Qualitative Concept]

Phrase: "or"

Phrase: "about 615 NTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0521175:Neuropil Threads [Acquired Abnormality]
   812   C0228081:Neuropil [Cell Component]
   812   C1710394:Thread [Manufactured Object]
   812   C1882475:Thread [Intellectual Product]

Phrase: "/hpf"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1552990:High Power Field [Quantitative Concept]
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1299351:High [Qualitative Concept]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C2700149:HIGH [Intellectual Product]
   827   C3539073:FIELD [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.91: a score of 3 = mild or approximately 1635 NTs/hpf; 

Phrase: "a score of 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449820:Score [Quantitative Concept]

Phrase: "= mild"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945599:Mild [Qualitative Concept]

Phrase: "or"

Phrase: "approximately 1635 NTs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0521175:Neuropil Threads [Acquired Abnormality]
   812   C0228081:Neuropil [Cell Component]
   812   C0332232:Approximately [Qualitative Concept]
   812   C1710394:Thread [Manufactured Object]
   812   C1882475:Thread [Intellectual Product]

Phrase: "/hpf"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1552990:High Power Field [Quantitative Concept]
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1299351:High [Qualitative Concept]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C2700149:HIGH [Intellectual Product]
   827   C3539073:FIELD [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.92: a score of 4 = moderate or about 3550 NTs/hpf; 

Phrase: "a score of 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449820:Score [Quantitative Concept]

Phrase: "= moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "or"

Phrase: "about 3550 NTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0521175:Neuropil Threads [Acquired Abnormality]
   812   C0228081:Neuropil [Cell Component]
   812   C1710394:Thread [Manufactured Object]
   812   C1882475:Thread [Intellectual Product]

Phrase: "/hpf"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1552990:High Power Field [Quantitative Concept]
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1299351:High [Qualitative Concept]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C2700149:HIGH [Intellectual Product]
   827   C3539073:FIELD [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.93: and a score of 5 = severe or about >50 NTs/hpf. 

Phrase: "and"

Phrase: "a score of 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449820:Score [Quantitative Concept]

Phrase: "= severe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severe [Qualitative Concept]

Phrase: "or"

Phrase: "about"

Phrase: ">50 NTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C0228081:Neuropil [Cell Component]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "/hpf."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1552990:High Power Field [Quantitative Concept]
   827   C0032863:Power [Human-caused Phenomenon or Process]
   827   C0205250:High [Qualitative Concept]
   827   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   827   C1299351:High [Qualitative Concept]
   827   C1521738:Field [Conceptual Entity]
   827   C2346620:Field [Conceptual Entity]
   827   C2349184:Field [Conceptual Entity]
   827   C2700149:HIGH [Intellectual Product]
   827   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.94: NTs were defined as curvilinear structures of narrow width and of variable length that stained brown or black, depending on the staining method. 

Phrase: "NTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "were"

Phrase: "defined as curvilinear structures of narrow width"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205168:Narrow [Qualitative Concept]
   748   C0332463:Narrow [Spatial Concept]
   748   C0333164:Narrow [Quantitative Concept]
   748   C0487742:Width [Quantitative Concept]
   748   C0678594:structures [Spatial Concept]
   748   C1704788:Defined [Conceptual Entity]
   748   C3539106:Defined [Intellectual Product]

Phrase: "and of variable length"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1706317:Long Variable [Qualitative Concept]
   770   C0439828:Variable [Qualitative Concept]
   770   C1444754:Length [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1706316:LENGTH [Research Activity]

Phrase: "that stained brown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "depending on the staining method."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0487602:Staining method [Laboratory Procedure]
           Staining
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   726   C0725813:depend [Medical Device]
Processing 00000000.tx.95: Statistical Analysis Our data were quantitative (counts) for LBs and NFTs and semiquantitative (ratings) for NTs. 

Phrase: "Statistical Analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "quantitative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392762:Quantitative [Quantitative Concept]

Phrase: "(counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439157:counts [Quantitative Concept]
   966 E C0750480:Count [Activity]
   966 E C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: "for LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "semiquantitative"

Phrase: "(ratings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0871208:Rating [Activity]

Phrase: ")"

Phrase: "for NTs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.96: We analyzed these variables as both dichotomous (present/absent) and counts and ratings. 

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "these variables as both dichotomous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439828:variables [Qualitative Concept]

Phrase: "(present/absent"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1709643:Present Absent [Conceptual Entity]
   861   C0332197:Absent [Quantitative Concept]
   861   C2699517:ABSENT [Finding]
   789 E C0424530:Absences [Finding]
   789 E C1689985:Absence [Anatomical Abnormality]

Phrase: ")"

Phrase: "and"

Phrase: "counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439157:counts [Quantitative Concept]
   966 E C0750480:Count [Activity]
   966 E C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "ratings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0871208:Rating [Activity]
Processing 00000000.tx.97: The primary outcomes of interest were the ability of different methods to detect (a) more cases with each pathological index, and (b) a greater number of each pathological index. 

Phrase: "The primary outcomes of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1274040:Outcome [Functional Concept]

Phrase: "were"

Phrase: "the ability of different methods to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "(a) more cases with each pathological index,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   757   C2597943:Index case [Temporal Concept]
   757   C2987736:Index Case [Population Group]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and ("

Phrase: "b) a greater number of each pathological index."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.98: Because this essentially amounts to measuring the same pathological index multiple times from the same subject under different experimental conditions, we employed repeated measures analyses, using the method of generalized estimating equations (Liang and Zeger 1986 ; Zeger and Liang 1986 ; Diggle et al. 1994 ). 

Phrase: "Because"

Phrase: "this essentially"

Phrase: "amounts to measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   790   C1265611:Amount [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the same pathological index multiple times from the same subject"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0040223:times [Temporal Concept]
   739   C1632851:Times [Quantitative Concept]
   706 E C3541383:Time [Temporal Concept]

Phrase: "under different experimental conditions,"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "we"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "repeated measures analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0871881:repeated measures [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method of generalized estimating equations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "(Liang"

Phrase: "and"

Phrase: "Zeger 1986"

Phrase: "; Zeger"

Phrase: "and"

Phrase: "Liang 1986"

Phrase: "; Diggle et al. 1994"

Phrase: ")."
Processing 00000000.tx.99: This method adjusts for the inherent correlation among measurements from the same subjects while also allowing one to model non-normal distributed data, such as dichotomous data, counts, and ratings. 

Phrase: "This method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "adjusts for the inherent correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707520:Correlation [Qualitative Concept]

Phrase: "among measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "from the same subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "while"

Phrase: "also"

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "one to model non-normal distributed data,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "such as dichotomous data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "counts,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439157:counts [Quantitative Concept]
   966 E C0750480:Count [Activity]
   966 E C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "ratings."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0871208:Rating [Activity]
Processing 00000000.tx.100: In addition, missing data are accommodated and need not be excluded. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1551393:Missing [Idea or Concept]
  1000   C1705492:Missing [Qualitative Concept]
  1000   C3272743:MISSING [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "accommodated"

Phrase: "and"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.101: We fit these models using PROC GENMOD in SAS, V. 

Phrase: "We"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "these models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PROC GENMOD in SAS,"

Phrase: "V."
Processing 00000000.tx.102: 6.12 (SAS Institute, Inc 1997 ). 

Phrase: "6.12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442752:6/12 [Finding]

Phrase: "(SAS Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Inc 1997"

Phrase: ")."
Processing 00000000.tx.103: We tested each given individual a priori hypothesis of interest using a Wald statistic. 

Phrase: "We"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "each given individual a priori hypothesis of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1512571:Hypothesis [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Wald statistic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2348149:Statistic [Quantitative Concept]
   861   C2828391:Statistic [Quantitative Concept]
   789 E C0038215:Statistical [Occupation or Discipline]
Processing 00000000.tx.104: Significance was determined at a level of p<0.05. 

Phrase: "Significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined at a level of p<0.05."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.105: Results Top Summary Introduction Materials and Methods Results Discussion Literature Cited Lewy Bodies We found that the number of cases detected with LB pathology did not significantly differ using -synuclein immunostaining compared with H&E or ubiquitin (z=1.37; p=0.085) (Table 1). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Lewy Bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the number of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "detected with LB pathology"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0085200:Lewy Body [Cell Component]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0242821:body [Human]
   760   C0442726:Detected [Finding]
   760   C0460148:Body [Anatomical Structure]
   760   C0677042:pathology [Pathologic Function]
   760   C1268086:Body [Anatomical Structure]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synuclein immunostaining"

Phrase: "compared with H&E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C1707455:Compared [Activity]

Phrase: "or"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(z=1.37"

Phrase: "; p=0.085"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.106: In addition, ubiquitin immunostaining did not improve case detection rate compared to H&E (z=1.44; p=0.074). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ubiquitin immunostaining"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "improve"

Phrase: "case detection rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0871208:Rate [Activity]
   827   C1511790:Detection [Therapeutic or Preventive Procedure]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "compared to H&E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C1707455:Compared [Activity]

Phrase: "(z=1.44"

Phrase: "; p=0.074"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.107: Conversely, the type of staining method significantly affected the number of LBs counted in hemisection. 

Phrase: "Conversely,"

Phrase: "the type of staining method significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the number of LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "counted in hemisection."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.108: We counted a significantly greater number of LBs using -synuclein compared to H&E and ubiquitin (z=4.88; p<0.001) (Table 1). 

Phrase: "We"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "a significantly greater number of LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compared to H&E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(z=4.88"

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: In addition, ubiquitin immunostaining allowed detection of significantly greater numbers of LBs compared to H&E (z=2.88; p= 0.002). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ubiquitin immunostaining allowed detection of significantly greater numbers of LBs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "compared to H&E"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0885297:eosin [Organic Chemical,Pharmacologic Substance]
   760   C1707455:Compared [Activity]

Phrase: "(z=2.88"

Phrase: "; p= 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.110: Of those with at least one LB, the median number of LBs was 5.5 using H&E, 10.5 using ubiquitin, and 19.4 using -synuclein immunostaining.  

Phrase: "Of those with"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332287:With [Qualitative Concept]
  1000   C1705690:With [Intellectual Product]

Phrase: "at least one LB,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0085200:Lewy Body [Cell Component]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   729 E C1995017:Bodies [Cell Component]

Phrase: "the median number of LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "5.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450380:5/5 [Quantitative Concept]
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "H&E,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10.5"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "19.4"

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synuclein immunostaining."
Processing 00000000.tx.111: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.112: Detection and number of Lewy bodies (LBs) in the substantia nigra Neurofibrillary Tangles and Neuropil Threads The number of cases identified with one or more NFTs was highest using Gallyas silver staining and PHF immunohistochemistry in bleached sections (41 and 40 cases, respectively; z=4.06; p<0.001) compared to all of the other methods (Table 2). 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "number of Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "(LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ")"

Phrase: "in the substantia nigra Neurofibrillary Tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "Neuropil Threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "The number of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "identified with one"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205396:Identified [Qualitative Concept]
   790   C0205447:One [Quantitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "or"

Phrase: "more NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "was"

Phrase: "highest"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C1522410:Highest [Qualitative Concept]
   966 E C0205250:High [Qualitative Concept]
   966 E C1299351:High [Qualitative Concept]
   966 E C2700149:HIGH [Intellectual Product]
   916 E C0489786:Height [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "PHF immunohistochemistry in bleached sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "(41"

Phrase: "and"

Phrase: "40 cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "respectively"

Phrase: "; z=4.06"

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared to all of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: "other methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.113: In addition, NFTs in the substantia nigra were observed in more cases using Gallyas silver staining (n=32) and PHF-1 immunostaining (n=37) compared to modified Bielschowsky silver staining (n=18).  

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "NFTs in the substantia nigra"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "were"

Phrase: "observed in more cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "(n=32"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PHF-1 immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: "(n=37"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared to modified Bielschowsky silver staining"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1293950:Silver Staining [Laboratory Procedure]
   753   C0037125:Silver [Element, Ion, or Isotope]
   753   C0392747:Modified [Functional Concept]
   753   C0487602:Staining [Laboratory Procedure]
   753   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   753   C1305285:Silver [Qualitative Concept]
   753   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   753   C1704680:Staining [Finding]
   753   C1707455:Compared [Activity]

Phrase: "(n=18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.114: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.115: Detection and number of neurofibrillary tangles (NFTs) in the substantia nigra in 45 patients with Alzheimer's disease The overall numbers of NFTs counted in hemisection was significantly greater using Gallyas and PHF after the bleaching of tissue sections compared to all of the other methods without bleach (z=8.21; p< 0.001; Table 2). 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "number of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "(NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ")"

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "in 45 patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "The overall numbers of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "counted in hemisection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "was"

Phrase: "significantly greater"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0443228:greater [Quantitative Concept]
   861   C1704243:Greater [Quantitative Concept]
   827 E C0549177:Great [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gallyas"

Phrase: "and"

Phrase: "PHF after the bleaching of tissue sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   742   C0010851:Filament [Cell Component]
   742   C1709450:Paired [Qualitative Concept]

Phrase: "compared to all of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Compared [Activity]

Phrase: "other methods without bleach"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "(z=8.21"

Phrase: "; p< 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: The absolute number of NFTs per hemisection observed with Gallyas or PHF after bleaching of melanin was more than 10-fold greater than the number observed by modified Bielschowsky and was more than 2.5 times greater than Gallyas or PHF staining alone (Fig 1A and Fig 1B). 

Phrase: "The absolute number of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "per hemisection"

Phrase: "observed with Gallyas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "or"

Phrase: "PHF after bleaching of melanin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   748   C0010851:Filament [Cell Component]
   748   C1709450:Paired [Qualitative Concept]

Phrase: "was"

Phrase: "more than 10-fold greater"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   797   C0439093:Greater Than [Quantitative Concept]
   760   C0205172:More [Functional Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   760   C1880834:FOLD [Phenomenon or Process]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "than the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "observed by modified Bielschowsky"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0205349:Modified By [Qualitative Concept]
   770   C0392747:Modified [Functional Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "more than 2.5 times"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   781   C0808270:Time 2 [Finding]
   760   C0040223:times [Temporal Concept]
   760   C0205172:More [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "greater than Gallyas"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "or"

Phrase: "PHF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "Fig 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: Gallyas and PHF after bleaching allowed similar increases in detection of NFTs (33.9  38.8 NFTs vs 30.6  35.8 NFTs; 2=1.86; p=0.173). 

Phrase: "Gallyas"

Phrase: "and"

Phrase: "PHF after bleaching allowed similar increases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   744   C0010851:Filament [Cell Component]
   744   C1709450:Paired [Qualitative Concept]

Phrase: "in detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(33.9  38.8 NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   793 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "vs"

Phrase: "30.6  35.8 NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   793 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "; 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "=1.86"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; p=0.173"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.118: Gallyas silver staining and PHF immunostaining alone (without prebleaching) allowed detection of a greater number of NFTs on average, per case, compared to Bielschowsky silver staining (z=3.16; p<0.001). 

Phrase: "Gallyas silver staining"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   901   C1293950:Silver Staining [Laboratory Procedure]
   884 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   827   C0037125:Silver [Element, Ion, or Isotope]
   827   C0487602:Staining [Laboratory Procedure]
   827   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   827   C1305285:Silver [Qualitative Concept]
   827   C1704680:Staining [Finding]
   793 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   743 E C0079853:Moon [Geographic Area]
   734 E C0003782:Argyria [Injury or Poisoning]
   734 E C3463959:Argyria [Eukaryote]

Phrase: "and"

Phrase: "PHF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "immunostaining"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "("

Phrase: "without prebleaching"

Phrase: ")"

Phrase: "allowed detection of a greater number of NFTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "on average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "per case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "compared to Bielschowsky silver staining"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1293950:Silver Staining [Laboratory Procedure]
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0487602:Staining [Laboratory Procedure]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   760   C1704680:Staining [Finding]
   760   C1707455:Compared [Activity]

Phrase: "(z=3.16"

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.119: View larger version (102K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(102K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.120: Improved detection of neurofibrillary pathology. 

Phrase: "Improved detection of neurofibrillary pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.121: (A) Neuromelanin obscures visualization of neurofibrillary pathology when PHF immunostaining is used. 

Phrase: "(A) Neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0068608:neuromelanin [Organic Chemical]

Phrase: "obscures"

Phrase: "visualization of neurofibrillary pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175631:Visualization [Mental Process]
   770   C2827662:Visualization [Occupation or Discipline]

Phrase: "when"

Phrase: "PHF immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.122: (Inset) NFT (large arrow) and neurons with neuromelanin (small arrow). 

Phrase: "(Inset"

Phrase: ")"

Phrase: "NFT (large arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "neurons with neuromelanin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(small arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.123: (B) NFTs and NTs are more easily detected when neuromelanin is bleached from tissue before PHF immunostaining. 

Phrase: "(B) NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "NTs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "are"

Phrase: "more easily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332219:Easily [Qualitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0068608:neuromelanin [Organic Chemical]

Phrase: "is"

Phrase: "bleached from tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040300:Tissue [Tissue]
   790   C0303749:bleached [Inorganic Chemical]
   790   C1547928:Tissue [Intellectual Product]

Phrase: "before PHF immunostaining."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]
Processing 00000000.tx.124: (Inset) Same NFT (large arrow) and neurons after tissue is bleached (small arrow). 

Phrase: "(Inset"

Phrase: ")"

Phrase: "Same NFT (large arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "neurons after tissue"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "is"

Phrase: "bleached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleached [Inorganic Chemical]

Phrase: "(small arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.125: Bars: A,B = 49.5 m; 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: ":"

Phrase: "A,B = 49.5 m"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   897   C2346751:A/m [Quantitative Concept]
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.126: insets = 16.5 m. 

Phrase: "insets"

Phrase: "= 16.5 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.127: The morphology of the NFTs using silver staining and PHF, with or without bleach, most often revealed the typical globose fibrillary structures (Fig 2A and Fig 2B). 

Phrase: "The morphology of the NFTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332437:Morphology [Qualitative Concept]
   753   C0543482:morphology [Spatial Concept]
   753   C0700329:Morphology, NOS [Finding]
   753   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "silver staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "PHF,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C0010851:Filament [Cell Component]
   827   C1709450:Paired [Qualitative Concept]
   755 E C1979891:Filamentous [Qualitative Concept]

Phrase: "with"

Phrase: "or without bleach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0303749:Bleach [Inorganic Chemical]

Phrase: "most often"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205393:Most [Quantitative Concept]
   861   C0332183:Often [Temporal Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the typical globose fibrillary structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:structures [Spatial Concept]

Phrase: "(Fig 2A"

Phrase: "and"

Phrase: "Fig 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.128: Using Gallyas after the bleaching of tissue sections additionally revealed small thread-like and linear intraneuronal tangles (Fig 2C). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gallyas after the bleaching of tissue sections additionally"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "small thread-like"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "and"

Phrase: "linear intraneuronal tangles"

Phrase: "(Fig 2C"

Phrase: ")."
Processing 00000000.tx.129: PHF immunostaining, particularly after bleach, also showed small intraneuronal tangle-like inclusions, as well as diffuse or dot-like staining occasionally extending into neuronal processes (Fig 2D). 

Phrase: "PHF immunostaining,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: "particularly"

Phrase: "after"

Phrase: "bleach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:Bleach [Inorganic Chemical]

Phrase: "also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "small intraneuronal tangle-like inclusions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C3553502:Intraneuronal inclusions [Finding]
   771   C1512693:Inclusion [Qualitative Concept]

Phrase: "as well as"

Phrase: "diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "or"

Phrase: "dot-like staining occasionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0872145:DOT [Therapeutic or Preventive Procedure]

Phrase: "extending into neuronal processes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   780   C0085103:neuron process [Cell Component]
   770   C0439792:Extending [Spatial Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   737 E C0231448:Extend [Functional Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "(Fig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.130: View larger version (67K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(67K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.131: Neurofibrillary tangles: typical globose neurofibrillary tangle using (A) Gallyas silver staining after bleach and (B) PHF immunostaining after bleach. 

Phrase: "Neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ":"

Phrase: "typical globose neurofibrillary tangle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085400:Neurofibrillary tangle [Acquired Abnormality]
   861   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(A) Gallyas silver staining after bleach"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C1293950:Silver Staining [Laboratory Procedure]
   773 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   767   C1293959:Bleach stain [Laboratory Procedure]
   753   C0037125:Silver [Element, Ion, or Isotope]
   753   C0487602:Staining [Laboratory Procedure]
   753   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   753   C1305285:Silver [Qualitative Concept]
   753   C1704680:Staining [Finding]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and ("

Phrase: "B) PHF immunostaining after bleach."
Processing 00000000.tx.132: Thread-like intraneuronal tangle using Gallyas silver staining after bleach (C). 

Phrase: "Thread-like intraneuronal tangle"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gallyas silver staining after bleach"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C1293950:Silver Staining [Laboratory Procedure]
   790 E C1318876:Silver stain [Indicator, Reagent, or Diagnostic Aid]
           Silver
   781   C1293959:Bleach stain [Laboratory Procedure]
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0487602:Staining [Laboratory Procedure]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.133: Diffuse PHF immunopositivity of nigral neurons with dendritic extension using PHF immunostaining after bleach (D). 

Phrase: "Diffuse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205219:Diffuse [Qualitative Concept]

Phrase: "PHF immunopositivity of nigral neurons"

Phrase: "with dendritic extension"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3157063:dendritic extension [Cell Function]
   861   C0231448:Extension [Functional Concept]
   861   C1880641:Extension [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PHF immunostaining after bleach"

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.134: Bars: A,B,D = 10 m; 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: ":"

Phrase: "A,B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "D ="

Phrase: "10 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.135: C = 15 m. 

Phrase: "C = 15 m."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C0601969:C 15 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.136: We identified neuropil threads (Fig 3) in the majority of cases of AD. 

Phrase: "We"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "(Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "in the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of AD."
Processing 00000000.tx.137: Depending on the method, 88100% of the cases of AD showed at least a few NTs. 

Phrase: "Depending on the method,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]
   737   C0725813:depend [Medical Device]

Phrase: "88100% of the cases of AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "showed at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "a few NTs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0521175:Neuropil Threads [Acquired Abnormality]
   793   C1710394:Thread [Manufactured Object]
   793   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.138: Semiquantitative estimates of the number of NTs were increased by the use of bleach (z=6.54; p<0.001) as compared to no bleach. 

Phrase: "Semiquantitative estimates of the number of NTs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0750572:estimates [Quantitative Concept]

Phrase: "were"

Phrase: "increased by the use of bleach"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0303749:Bleach [Inorganic Chemical]
   753   C0442805:Increased [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "(z=6.54"

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "as"

Phrase: "compared to no bleach."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0303749:Bleach [Inorganic Chemical]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.139: In addition, PHF after bleaching allowed visualization of more threads (mean score 3.2  1.4) compared to Gallyas after bleaching (2.3  1.4) (2 = 50.75; p<0.001). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "PHF after bleaching allowed visualization of more"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   742   C0010851:Filament [Cell Component]
   742   C1709450:Paired [Qualitative Concept]

Phrase: "threads"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710394:Thread [Manufactured Object]
  1000   C1882475:Thread [Intellectual Product]

Phrase: "(mean score 3.2  1.4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C3533236:Mean score [Quantitative Concept]
   799   C0444504:Mean [Quantitative Concept]
   799   C0449820:Score [Quantitative Concept]
   799   C2347634:Mean [Quantitative Concept]
   799   C2348143:Mean [Quantitative Concept]

Phrase: ")"

Phrase: "compared to Gallyas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "after bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleaching [Inorganic Chemical]

Phrase: "(2.3  1.4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1519042:2-3 [Research Activity]
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "= 50.75"

Phrase: "; p<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.140: View larger version (61K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(61K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.141: Neuropil threads. 

Phrase: "Neuropil threads."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.142: Many neuropil threads are seen with PHF immunostaining after bleach. 

Phrase: "Many neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "are"

Phrase: "seen with PHF immunostaining"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   753   C0010851:Filament [Cell Component]
   753   C0205397:Seen [Qualitative Concept]
   753   C1709450:Paired [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "after bleach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:Bleach [Inorganic Chemical]
Processing 00000000.tx.143: Bar = 20 m. 

Phrase: "Bar = 20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.144: The distribution of neurofibrillary pathology within the substantia nigra was not specifically addressed in this study. 

Phrase: "The distribution of neurofibrillary pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "within the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "not specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "addressed in this study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C0376649:Address [Intellectual Product]
   737   C1442065:Address [Spatial Concept]
Processing 00000000.tx.145: However, neurofibrillary pathology was observed throughout the hemisection of nigra rather than confined to a particular anatomic locus within the nucleus. 

Phrase: "However,"

Phrase: "neurofibrillary pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "was"

Phrase: "observed throughout the hemisection of nigra"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1441672:Observed [Functional Concept]

Phrase: "rather than"

Phrase: "confined to a particular anatomic locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220784:anatomic [Qualitative Concept]
   753   C1708726:Locus [Gene or Genome]

Phrase: "within the nucleus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.146: Discussion Top Summary Introduction Materials and Methods Results Discussion Literature Cited Specific stains and the bleaching of tissue sections to remove neuromelanin before staining dramatically improve detection of LBs and neurofibrillary pathology in the substantia nigra in AD. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Specific stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "the bleaching of tissue sections to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0303749:bleaching [Inorganic Chemical]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "neuromelanin before staining dramatically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0068608:neuromelanin [Organic Chemical]

Phrase: "improve"

Phrase: "detection of LBs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "neurofibrillary pathology in the substantia nigra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]

Phrase: "in AD."
Processing 00000000.tx.147: -Synuclein and ubiquitin immunostaining did not increase the number of cases uncovered with LB pathology. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ubiquitin immunostaining"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the number of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "uncovered with LB pathology."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0085200:Lewy Body [Cell Component]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0242821:body [Human]
   760   C0439845:Uncovered [Functional Concept]
   760   C0460148:Body [Anatomical Structure]
   760   C0677042:pathology [Pathologic Function]
   760   C1268086:Body [Anatomical Structure]
Processing 00000000.tx.148: However, -synuclein and, to a lesser extent, ubiquitin allowed visualization of increased numbers of nigral LBs per case. 

Phrase: "However, -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: ","

Phrase: "to a lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "visualization of increased numbers of nigral LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0175631:Visualization [Mental Process]
   744   C2827662:Visualization [Occupation or Discipline]

Phrase: "per case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.149: Pretreatment with bleach significantly increased both the numbers of cases detected with neurofibrillary pathology and the amount of neurofibrillary pathology detected on average per case. 

Phrase: "Pretreatment with bleach significantly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1550147:Pretreatment [Substance]
   770   C2709094:pre treatment [Temporal Concept]
   770   C3539075:Pretreatment [Temporal Concept]
   770   C3539076:Pretreatment [Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "both the numbers of cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "detected with neurofibrillary pathology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0442726:Detected [Finding]
   770   C0677042:pathology [Pathologic Function]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the amount of neurofibrillary pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "detected on average"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442726:Detected [Finding]
   790   C1510992:Average [Quantitative Concept]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C2825518:AVERAGE [Quantitative Concept]

Phrase: "per case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.150: Using the bleaching method, approximately 90% of AD cases showed NFTs, with NFT counts approximately 10-fold greater on average per case (compared to unbleached sections), and all cases displayed at least a few NTs. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the bleaching method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "approximately 90% of AD cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0332232:Approximately [Qualitative Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "NFTs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "with NFT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "counts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439157:counts [Quantitative Concept]
  1000   C0750480:Count [Activity]
  1000   C1705566:Count [Quantitative Concept]

Phrase: "approximately 10-fold greater on average"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "per case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "("

Phrase: "compared to unbleached sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "displayed at least"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0870432:displayed [Functional Concept]
   756 E C1705417:Display [Manufactured Object]

Phrase: "a few NTs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0521175:Neuropil Threads [Acquired Abnormality]
   793   C1710394:Thread [Manufactured Object]
   793   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.151: Few previous studies have investigated detection of nigral pathology in AD comparing different histological stains or tissue bleaching before staining (Uchihara et al. 1995 ; Irizarry et al. 1998 ). 

Phrase: "Few previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "investigated detection of nigral pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in AD"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "different histological stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "tissue bleaching before staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0303749:bleaching [Inorganic Chemical]

Phrase: "(Uchihara et al. 1995"

Phrase: "; Irizarry et al. 1998"

Phrase: ")."
Processing 00000000.tx.152: In one study, the number of -synuclein-immunopositive structures was found to exceed that of ubiquitin (Irizarry et al. 1998 ). 

Phrase: "In one study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the number of -synuclein-immunopositive structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0678594:structures [Spatial Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exceed"

Phrase: "that of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Irizarry et al. 1998"

Phrase: ")."
Processing 00000000.tx.153: LB case detection and the magnitude of the difference were not addressed. 

Phrase: "LB case detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the magnitude of the difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.154: In a second study, Gallyas silver impregnation after bleaching revealed an unexpectedly large number of NFTs in five cases of AD (Uchihara et al. 1995 ). 

Phrase: "In a second study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "Gallyas silver impregnation after bleaching"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1293950:silver impregnation [Laboratory Procedure]
   760   C0015914:impregnation [Organism Function]
   760   C0037125:Silver [Element, Ion, or Isotope]
   760   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   760   C1305285:Silver [Qualitative Concept]
   760   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an unexpectedly large number of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "in five cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "of AD (Uchihara et al. 1995"

Phrase: ")."
Processing 00000000.tx.155: These investigators did not use immunostains after bleach pretreatment, nor did they apply these methods to cases with little or no pathology. 

Phrase: "These investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "immunostains after bleach pretreatment,"

Phrase: "nor"

Phrase: "did"

Phrase: "they"

Phrase: "apply"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]

Phrase: "these methods to cases"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "with little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.156: The protein -synuclein is one of the integral components of LBs in Parkinson's disease, LB disease, and AD with LB (Irizarry et al. 1998 ; Spillantini et al. 1998 ). 

Phrase: "The protein -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "one of the integral components of LBs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "in Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "LB disease,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0752347:Lewy Body Disease [Disease or Syndrome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   743 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "AD with LB"

Phrase: "(Irizarry et al. 1998"

Phrase: "; Spillantini et al. 1998"

Phrase: ")."
Processing 00000000.tx.157: Double immunofluorescence studies have shown the presence of -synuclein-immunopositive, ubiquitin-immunonegative LBs (Irizarry et al. 1998 ). 

Phrase: "Double immunofluorescence studies"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   827   C0205173:Double [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1705764:Double [Activity]
   827   C1705765:Double [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the presence of -synuclein-immunopositive, ubiquitin-immunonegative LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0085200:Lewy Bodies [Cell Component]
   793   C0242821:bodies [Human]
   793   C1995017:Bodies [Cell Component]
   760 E C0460148:Body [Anatomical Structure]
   760 E C1268086:Body [Anatomical Structure]

Phrase: "(Irizarry et al. 1998"

Phrase: ")."
Processing 00000000.tx.158: Our study supports the notion that -synuclein immunostaining has a higher sensitivity for LBs than ubiquitin. 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that -synuclein immunostaining"

Phrase: "has"

Phrase: "a higher sensitivity for LBs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C1441604:High sensitivity [Laboratory Procedure]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "than ubiquitin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.159: This may be explained partly by the fact that -synuclein is present at an earlier stage of LB formation, e.g., pale bodies (intracytoplasmic pale eosinophilic inclusions lacking the peripheral halo) often considered a precursor to LBs. 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "explained"

Phrase: "partly by the fact"

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "present at an earlier stage of LB formation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "e.g."

Phrase: ","

Phrase: "pale bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C3546242:pale body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(intracytoplasmic pale eosinophilic inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1711292:Intracytoplasmic Eosinophilic Inclusion [Finding]
   861   C3279277:Eosinophilic inclusions [Finding]
   779   C1512693:Inclusion [Qualitative Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the peripheral halo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0271188:HALO [Sign or Symptom]
   861   C3541466:halo [Cell Component]

Phrase: ")"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a precursor to LBs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.160: Unlike ubiquitin, which may immunostain other neuronal inclusions, e.g., neurofibrillary pathology, -synuclein immunostaining is relatively specific for LBs (Irizarry et al. 1998 ; and personal observations). 

Phrase: "Unlike ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "may"

Phrase: "immunostain"

Phrase: "other neuronal inclusions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "e.g."

Phrase: ","

Phrase: "neurofibrillary pathology, -"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "synuclein immunostaining"

Phrase: "is"

Phrase: "relatively specific for LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "(Irizarry et al. 1998"

Phrase: ";"

Phrase: "and"

Phrase: "personal observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.161: -Synuclein positivity is, however, also found in oligodendroglial inclusions of multiple system atrophy (Wakabayashi et al. 1998 ). 

Phrase: "-Synuclein positivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C0439178:% Positive [Quantitative Concept]
   789   C1446409:Positive [Qualitative Concept]
   789   C1514241:Positive [Finding]
   789   C2825490:Positive [Qualitative Concept]

Phrase: "is"

Phrase: ","

Phrase: "however,"

Phrase: "also"

Phrase: "found in oligodendroglial inclusions of multiple system atrophy"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0037019:Multiple System Atrophy [Disease or Syndrome]
   800   C0393571:Multiple System Atrophy [Disease or Syndrome]
   744   C0150312:Found [Quantitative Concept]
   744   C0333641:Atrophy [Pathologic Function]
   744   C0439064:Multiple [Quantitative Concept]
   744   C0449913:System [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   711 E C0243095:Find [Finding]
   711   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Wakabayashi et al. 1998"

Phrase: ")."
Processing 00000000.tx.162: Most previous literature of NFTs in AD suggest that neurofibrillary pathology in the substantia nigra is uncommon (Forno and Alvord 1971 ; Tomlinson and Corsellis 1984 ; Tabaton et al. 1985 ; Perry 1986 ; German et al. 1987 ; Parvizi et al. 2001 ), remains confined to the ventral tegmental area (Ishii 1966 ; Tomlinson and Corsellis 1984 ; Bondareff et al. 1994 ; Parvizi et al. 2001 ) and, when present, occurs late in the course of the disease (Braak and Braak 1991 ). 

Phrase: "Most previous literature of NFTs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0023866:Literature [Intellectual Product]
   753   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "in AD"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that neurofibrillary pathology in the substantia nigra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0677042:pathology [Pathologic Function]

Phrase: "is"

Phrase: "uncommon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522498:Uncommon [Qualitative Concept]

Phrase: "(Forno"

Phrase: "and"

Phrase: "Alvord 1971"

Phrase: "; Tomlinson"

Phrase: "and"

Phrase: "Corsellis 1984"

Phrase: "; Tabaton et al. 1985"

Phrase: "; Perry 1986"

Phrase: "; German et al. 1987"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1556085:German [Population Group]

Phrase: "; Parvizi et al. 2001"

Phrase: ")"

Phrase: ","

Phrase: "remains"

Phrase: "confined to the ventral tegmental area"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]
   753   C1704448:Ventral [Spatial Concept]

Phrase: "(Ishii 1966"

Phrase: "; Tomlinson"

Phrase: "and"

Phrase: "Corsellis 1984"

Phrase: "; Bondareff et al. 1994"

Phrase: "; Parvizi et al. 2001"

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "when"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "late in the course of the disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0242656:disease course [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205087:Late [Temporal Concept]
   748   C0750729:Course [Temporal Concept]

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak 1991"

Phrase: ")."
Processing 00000000.tx.163: Although one study reported widespread NFTs in up to 50% of the SN examined (Gibb et al. 1989 ), others describe nigral NFTs in less than 15% of their AD cases, and a more localized distribution (Forno and Alvord 1971 ; Parvizi et al. 2001 ). 

Phrase: "Although"

Phrase: "one study reported widespread NFTs in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "up to 50%"

Phrase: "of the SN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Gibb et al. 1989"

Phrase: ")"

Phrase: ","

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "describe"

Phrase: "nigral NFTs in less"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "than 15%"

Phrase: "of their AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "a more localized distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0520511:distribution [Idea or Concept]
   827   C1704711:Distribution [Functional Concept]

Phrase: "(Forno"

Phrase: "and"

Phrase: "Alvord 1971"

Phrase: "; Parvizi et al. 2001"

Phrase: ")."
Processing 00000000.tx.164: The magnitude of neurofibrillary pathology in the substantia nigra is also generally considered small, with as few as five NFTs per section (Tabaton et al. 1985 ) to three per microscopic field on 50-m sections (Parvizi et al. 2001 ). 

Phrase: "The magnitude of neurofibrillary pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "in the substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "also generally"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "with"

Phrase: "as"

Phrase: "few as five NFTs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]
   760   C0205388:Few [Quantitative Concept]
   760   C0205451:Five [Quantitative Concept]

Phrase: "per section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: "(Tabaton et al. 1985"

Phrase: ")"

Phrase: "to three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "per microscopic field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   861   C1521738:Field [Conceptual Entity]
   861   C2346620:Field [Conceptual Entity]
   861   C2349184:Field [Conceptual Entity]
   861   C3539073:FIELD [Spatial Concept]

Phrase: "on 50-m sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "(Parvizi et al. 2001"

Phrase: ")."
Processing 00000000.tx.165: None of these studies used bleach before silver or immunohistochemical staining. 

Phrase: "None of these studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bleach before silver"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0303749:Bleach [Inorganic Chemical]

Phrase: "or"

Phrase: "immunohistochemical staining."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1441616:Immunohistochemical [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.166: Improved visualization of nigral neurofibrillary pathology after bleaching could result from unveiling of perikaryal structures or from decreased neuropil staining. 

Phrase: "Improved visualization of nigral neurofibrillary pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175631:Visualization [Mental Process]
   753   C2827662:Visualization [Occupation or Discipline]

Phrase: "after bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleaching [Inorganic Chemical]

Phrase: "could"

Phrase: "result from unveiling of perikaryal structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0678594:structures [Spatial Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "or from decreased neuropil staining."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0228081:Neuropil [Cell Component]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.167: The occasional diffuse staining of cell bodies and extensions with PHF immunostaining after bleaching may suggest detection of an earlier stage of NFT development. 

Phrase: "The occasional diffuse staining of cell bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "extensions with PHF immunostaining"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0231448:extensions [Functional Concept]
   719 E C1880641:Extension [Conceptual Entity]

Phrase: "after bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleaching [Inorganic Chemical]

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "detection of an earlier stage of NFT development."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0596473:Early Detection [Diagnostic Procedure]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.168: During neurofibrillary degeneration, differential stages are recognized by ultrastructural and immunohistochemical changes (Bondareff et al. 1994 ). 

Phrase: "During neurofibrillary degeneration,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "differential stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "are"

Phrase: "recognized by ultrastructural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0041623:Ultrastructure [Idea or Concept]

Phrase: "and"

Phrase: "immunohistochemical changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "(Bondareff et al. 1994"

Phrase: ")."
Processing 00000000.tx.169: Oxidation-dependent epitopes, such as post-translational modifications, have been strongly implicated in the formation of NFTs (Smith et al. 1995 ). 

Phrase: "Oxidation-dependent epitopes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "such as post-translational modifications,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modifications [Molecular Function]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1704687:Post [Manufactured Object]
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "strongly"

Phrase: "implicated in the formation of NFTs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Smith et al. 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0554249:Smith [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.170: Epitopes may be made available through oxidation (bleaching). 

Phrase: "Epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitopes [Immunologic Factor]

Phrase: "may"

Phrase: "be"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "available through oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "(bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleaching [Inorganic Chemical]

Phrase: ")."
Processing 00000000.tx.171: Artifactual staining is unlikely, given the variability of staining between cases, between NFTs and NTs, and the characteristic morphology of NFTs and NTs. 

Phrase: "Artifactual staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "unlikely,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the variability of staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827666:Variability [Conceptual Entity]

Phrase: "between cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "between NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "NTs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "and"

Phrase: "the characteristic morphology of NFTs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332437:Morphology [Qualitative Concept]
   753   C0543482:morphology [Spatial Concept]
   753   C0700329:Morphology, NOS [Finding]
   753   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "NTs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.172: The impact of these findings on the pathologic diagnoses of diseases with LBs (e.g., dementia with Lewy bodies) remains uncertain. 

Phrase: "The impact of these findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "on the pathologic diagnoses"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   947   C0332142:Pathology diagnosis [Functional Concept]
   861   C0011900:Diagnoses [Finding]
   861   C1521733:Pathologic [Functional Concept]
   827 E C1704338:diagnosis [Qualitative Concept]
   827 E C1704656:DIAGNOSIS [Research Activity]
   789 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]

Phrase: "of diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "with LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "("

Phrase: "e.g."

Phrase: ","

Phrase: "dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "remains"

Phrase: "uncertain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0087130:Uncertain [Idea or Concept]
Processing 00000000.tx.173: Although we did not increase case detection for LBs using -synuclein, our study did not include evaluation of the cortex or assess severity of disease, and therefore it remains to be determined whether -synuclein better detects cases with cortical LBs or nigral LB pathology in asymptomatic or early-stage disease. 

Phrase: "Although"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "case detection for LBs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "evaluation of the cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]

Phrase: "or"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "severity of disease,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   858   C0521117:disease severity [Qualitative Concept]
   790   C0439793:Severity [Qualitative Concept]
   790   C2983285:Severity [Intellectual Product]
   718 E C0205082:Severe [Qualitative Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "it"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "cases with cortical LBs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "or"

Phrase: "nigral LB pathology in asymptomatic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]

Phrase: "or"

Phrase: "early-stage disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0679245:early disease [Temporal Concept]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   734   C1517886:Early Stage [Classification]
   734   C2363430:Early stage [Temporal Concept]
Processing 00000000.tx.174: It is interesting to note that, compared to "pure" AD, there are fewer NFTs in the substantia nigra in cases of AD with nigral LB. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that,"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "to ""pure"" AD,"

Phrase: "there"

Phrase: "are"

Phrase: "fewer NFTs in the substantia nigra"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of AD"

Phrase: "with nigral LB."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0085200:Lewy Body [Cell Component]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.175: Nevertheless, improved detection of neurofibrillary pathology is noted for both groups (Table 3). 

Phrase: "Nevertheless,"

Phrase: "improved detection of neurofibrillary pathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "noted for both groups"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.176: Fewer neocortical NFTs have been previously reported in AD with LBs (Hansen et al. 1993 ). 

Phrase: "Fewer neocortical NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "reported in AD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "with LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(Hansen et al. 1993"

Phrase: ")."
Processing 00000000.tx.177: Because LB cases typically have significant nigral neuronal loss, further studies evaluating nigral NFTs in AD with and without LBs will require a wide spectrum of change to account for neuron loss. 

Phrase: "Because"

Phrase: "LB cases typically"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "have"

Phrase: "significant nigral neuronal loss,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1850496:Neuronal loss [Finding]
   825 E C0598940:neuron loss [Finding]
   812   C1517945:Loss [Quantitative Concept]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "evaluating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0220825:Evaluate [Functional Concept]

Phrase: "nigral NFTs in AD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "with"

Phrase: "and without LBs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1515981:And [Idea or Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "will"

Phrase: "require"

Phrase: "a wide spectrum of change to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332464:Wide [Spatial Concept]
   753   C1883073:Spectrum [Quantitative Concept]
   753   C2827424:Spectrum [Conceptual Entity]

Phrase: "account for neuron loss."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0598940:neuron loss [Finding]
   797 E C1850496:Neuronal loss [Finding]
   770   C0027882:Neuron [Cell]
   770   C1517945:Loss [Quantitative Concept]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
Processing 00000000.tx.178: Unlike the diseases with LBs for which the diagnosis relies on LBs at one or multiple sites, a pathological diagnosis of AD is not rendered on the basis of NFTs in the substantia nigra, and therefore the bleaching method is unlikely to affect diagnosis.  

Phrase: "Unlike the diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "with LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "for which"

Phrase: "the diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "relies on LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "at one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "multiple sites,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "a pathological diagnosis of AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332142:Pathology diagnosis [Functional Concept]
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rendered on the basis of NFTs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C1527178:Basis [Functional Concept]
   748   C1874451:Basis [Pharmacologic Substance]
   745 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "in the substantia nigra,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "therefore"

Phrase: "the bleaching method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "diagnosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.179: View this table: [in this window] [in a new window]  Table 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.180: Alzheimer's disease without nigral Lewy bodies (AD/no LB) and Alzheimer's disease with nigral Lewy bodies (AD + LB): detection and number of neurofibrillary tangles (NFTs) in the substantia nigraa The implications of these findings for clinical pathologic and other research studies, where it is useful to use the most sensitive method to detect pathology, are apparent. 

Phrase: "Alzheimer's disease without nigral Lewy bodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0752347:bodies disease lewy [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "(AD/"

Phrase: "no LB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085200:Lewy Body [Cell Component]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "Alzheimer's disease with nigral Lewy bodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0752347:bodies disease lewy [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "(AD + LB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0085200:Lewy Body [Cell Component]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]

Phrase: ")"

Phrase: ":"

Phrase: "detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "number of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "(NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ")"

Phrase: "in the substantia nigraa"

Phrase: "The implications of these findings"

Phrase: "for clinical pathologic"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   964   C0030667:Pathology, Clinical [Biomedical Occupation or Discipline]
   861   C1521733:Pathologic [Functional Concept]
   789 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "other research studies,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0681814:research studies [Research Activity]
   966 E C1556037:Research Study [Professional or Occupational Group]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "where"

Phrase: "it"

Phrase: "is"

Phrase: "useful to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the most sensitive method to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
   708   C0332324:Sensitive to [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "are"

Phrase: "apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.181: Our results support the second Dementia with Lewy Body International Workshop (McKeith et al. 1999 ) suggestion of using -synuclein for LB detection in clinicopathological correlative studies. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the second Dementia with Lewy Body International Workshop"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           Dementia, Lewy Body
   793   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   735   C0856416:secondary dementia [Mental or Behavioral Dysfunction]

Phrase: "(McKeith et al. 1999"

Phrase: ")"

Phrase: "suggestion of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0038659:Suggestion [Idea or Concept]
   833   C1705535:suggestion [Idea or Concept]

Phrase: "using -"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "synuclein for LB detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in clinicopathological correlative studies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   867   C1511524:Correlative Study [Research Activity]
           Correlative
   827   C0947630:studies [Laboratory Procedure]
   827   C1707520:Correlative [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
Processing 00000000.tx.182: Although the clinical correlate of the number of nigral LB has not been well studied in AD, absolute LB counts in the neocortex using ubiquitin immunohistochemistry may be related to cognitive status in LB disease (Samuel et al. 1996 ). 

Phrase: "Although"

Phrase: "the clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "correlate of the number of nigral LB"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0085200:Lewy Body [Cell Component]
   744   C0237753:*Number [Quantitative Concept]
   744   C0242821:body [Human]
   744   C0449788:Number [Quantitative Concept]
   744   C0460148:Body [Anatomical Structure]
   744   C1268086:Body [Anatomical Structure]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "well studied in AD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "absolute LB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0085200:Lewy Body [Cell Component]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]

Phrase: "counts in the neocortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0175173:Neocortex [Body Part, Organ, or Organ Component]
   770   C0439157:counts [Quantitative Concept]
   770   C0750480:Count [Activity]
   770   C1705566:Count [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ubiquitin immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "related to cognitive status"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0449438:Status [Qualitative Concept]
   770   C1516691:Cognitive [Functional Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "in LB disease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0752347:Lewy Body Disease [Disease or Syndrome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   743 E C1995017:Bodies [Cell Component]

Phrase: "(Samuel et al. 1996"

Phrase: ")."
Processing 00000000.tx.183: In addition, our results suggest that Gallyas or PHF immunostaining with bleach to improve NFT detection may have an impact on clinicopathological correlative studies investigating NFTs in the substantia nigra. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Gallyas"

Phrase: "or"

Phrase: "PHF immunostaining with bleach to"

Phrase: "improve"

Phrase: "NFT detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "have"

Phrase: "an impact on clinicopathological correlative studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "NFTs in the substantia nigra."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.184: Only recently have NFTs been considered as an etiological factor for parkinsonism in cases of AD without LBs (Liu et al. 1997 ). 

Phrase: "Only recently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0332185:Recently [Temporal Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "have"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "been"

Phrase: "considered as an etiological factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0750591:considered [Idea or Concept]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "for parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "in cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "of AD"

Phrase: "without LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(Liu et al. 1997"

Phrase: ")."
Processing 00000000.tx.185: In persons with AD and parkinsonism, the neuropathological substrate underlying the motor disorder often remains speculative (Morris et al. 1989 ). 

Phrase: "In persons"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027361:Persons [Population Group]
   966 E C2347489:Person [Group]
   916 E C1519021:Personal [Organism Attribute]

Phrase: "with AD"

Phrase: "and"

Phrase: "parkinsonism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "the neuropathological substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "underlying"

Phrase: "the motor disorder often"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0221163:Motor disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]
   827   C1513492:Motor [Functional Concept]
   827   C1705994:Motor [Manufactured Object]

Phrase: "remains"

Phrase: "speculative"

Phrase: "(Morris et al. 1989"

Phrase: ")."
Processing 00000000.tx.186: Indeed, the etiology of parkinsonism in AD may include more than one neuropathological substrate in the SN in addition to neuropathological changes outside the SN. 

Phrase: "Indeed,"

Phrase: "the etiology of parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015127:aetiology [Functional Concept]
   770   C1314792:Aetiology [Functional Concept]
   770   C1524003:Etiology [Conceptual Entity]

Phrase: "in AD"

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "more than one neuropathological substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205172:More [Functional Concept]
   760   C0205447:One [Quantitative Concept]
   760   C1710236:Substrate [Manufactured Object]

Phrase: "in the SN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "in addition to neuropathological changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the SN."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
Processing 00000000.tx.187: One of the factors in determining the relationship of these pathologies to clinical signs is the method used to detect their occurrence in the postmortem brain. 

Phrase: "One of the factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "in determining"

Phrase: "the relationship of these pathologies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "to clinical signs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3540840:CLINICAL SIGNS [Finding]
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "is"

Phrase: "the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "their occurrence in the postmortem brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243132:occurrence [Functional Concept]
   753   C1554210:occurrence [Idea or Concept]
   753   C2745955:Occurrence [Temporal Concept]
Processing 00000000.tx.188: Because parkinsonism in persons with AD is common (Molsa et al. 1984 ; Chang Chui et al. 1985 ; Mayeux et al. 1985 ; Wilson et al. 2000a ) and is associated with morbidity and mortality (Richards et al. 1993 ; Stern et al. 1994 ; Bennett et al. 1998 ; Wilson et al. 2000b ), it is important to extend our findings by determining the overall contribution of these nigral cytoskeletal changes to clinical signs in AD. 

Phrase: "Because"

Phrase: "parkinsonism in persons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "with AD"

Phrase: "is"

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "(Molsa et al. 1984"

Phrase: "; Chang Chui et al. 1985"

Phrase: "; Mayeux et al. 1985"

Phrase: "; Wilson et al. 2000a"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "associated with morbidity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026538:Morbidity [Quantitative Concept]
   790   C0220880:morbidity [Intellectual Product]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "(Richards et al. 1993"

Phrase: "; Stern et al. 1994"

Phrase: "; Bennett et al. 1998"

Phrase: "; Wilson et al. 2000b"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our findings by determining"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0037088:Finding [Sign or Symptom]
   737 E C0243095:Finding [Finding]
   737 E C2825141:Finding [Finding]

Phrase: "the overall contribution of these nigral cytoskeletal changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "to clinical signs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C3540840:CLINICAL SIGNS [Finding]
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "in AD."
Processing 00000000.tx.189: The present investigation provides striking evidence that use of specific stains and bleaching of neuromelanin from neurons of the SN greatly enhances the visualization of LBs and neurofibrillary pathology in these perikarya. 

Phrase: "The present investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "striking evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that use of specific stains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "bleaching of neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0303749:bleaching [Inorganic Chemical]

Phrase: "from neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of the SN greatly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   901   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the visualization of LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175631:Visualization [Mental Process]
   760   C2827662:Visualization [Occupation or Discipline]

Phrase: "and"

Phrase: "neurofibrillary pathology in these perikarya."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.190: These improved staining methods will provide basic researchers with a more sensitive tool for the evaluation of cytological degeneration in the SN and its relationship to cognitive and motor function. 

Phrase: "These improved staining methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C0487602:Staining method [Laboratory Procedure]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "will"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "basic researchers with a more sensitive tool"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035173:Researchers [Professional or Occupational Group]

Phrase: "for the evaluation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220825:Evaluation [Functional Concept]
  1000   C1261322:Evaluation [Health Care Activity]

Phrase: "of cytological degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "in the SN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "its relationship to cognitive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "motor function."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0234130:Motor function [Functional Concept]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1513492:Motor [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   861   C1705994:Motor [Manufactured Object]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.191: Acknowledgments Supported by grants from the National Institute on Aging (AG10161, AG14449, AG09966, AG09466, AG00849) and the Elsie Heller Fund. 

Phrase: "Acknowledgments"

Phrase: "Supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institute on Aging"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1955974:National Institute on Aging [Health Care Related Organization]
   812   C0001811:Ageing [Organism Function]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]
   812   C3245503:national [Intellectual Product]
   779 E C0001779:Age [Organism Attribute]

Phrase: "(AG10161,"

Phrase: "AG14449,"

Phrase: "AG09966,"

Phrase: "AG09466,"

Phrase: "AG00849"

Phrase: ")"

Phrase: "and"

Phrase: "the Elsie Heller Fund."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016820:Fund [Quantitative Concept]
Processing 00000000.tx.192: We wish to thank Woojeong Bang for assistance with computer programming and Jia-liang Li for assistance in the laboratory. 

Phrase: "We"

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Woojeong Bang for assistance"

Phrase: "with computer programming"

Phrase: "and"

Phrase: "Jia-liang Li for assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "in the laboratory."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]
Processing 00000000.tx.193: Received for publication February 20, 2001; 

Phrase: "Received for publication February 20,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.194: accepted August 2, 2001. 

Phrase: "accepted August 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.195: Literature Cited Top Summary Introduction Materials and Methods Results Discussion Literature Cited Bennett D, Beckett L, Wilson RS, Murray AM, Evans DA (1998) Parkinsonian signs and mortality from Alzheimer's disease. 

Phrase: "Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Bennett D,"

Phrase: "Beckett L,"

Phrase: "Wilson RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Murray"

Phrase: "AM"

Phrase: ","

Phrase: "Evans DA (1998"

Phrase: ")"

Phrase: "Parkinsonian signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "and"

Phrase: "mortality from Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0681679:disease mortality [Quantitative Concept]
   770   C0026565:Mortality [Quantitative Concept]
   770   C0026566:mortality [Quantitative Concept]
Processing 00000000.tx.196: Lancet 351:1631[Medline] Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. 

Phrase: "Lancet 351"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: ":"

Phrase: "1631"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Braak E (1991"

Phrase: ")"

Phrase: "Neuropathological staging of Alzheimer-related changes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0332305:Staging [Functional Concept]
   750   C0679846:change stage [Intellectual Product]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]
   719 E C1306673:Stage [Qualitative Concept]
Processing 00000000.tx.197: Acta Neuropathol (Berl) 82:239-259[Medline] Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M (1994) Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "82"

Phrase: ":"

Phrase: "239-259"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bondareff W,"

Phrase: "Harrington C,"

Phrase: "Wischik CM,"

Phrase: "Hauser DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Roth"

Phrase: "M ("

Phrase: "1994"

Phrase: ")"

Phrase: "Immunohistochemical staging of neurofibrillary degeneration"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0332305:Staging [Functional Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]
   726 E C1306673:Stage [Qualitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.198: J Neuropathol Exp Neurol 53:158-164[Medline] Chang Chui H, Lee Teng E, Henderson V, Moy A (1985) Clinical subtypes of dementia of the Alzheimer type. 

Phrase: "J Neuropathol Exp Neurol 53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "158-164"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chang Chui H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Lee Teng E,"

Phrase: "Henderson V,"

Phrase: "Moy A (1985"

Phrase: ")"

Phrase: "Clinical subtypes of dementia of the Alzheimer type."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449560:subtypes [Classification]
Processing 00000000.tx.199: Neurology 35:1544-1550[Abstract] Diggle PJ, Liang K-Y, Zeger SL (1994) Analysis of Longitudinal Data. 

Phrase: "Neurology 35"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "1544-1550"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Diggle PJ,"

Phrase: "Liang K-Y,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Zeger SL (1994"

Phrase: ")"

Phrase: "Analysis of Longitudinal Data."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0010992:Data Analysis [Occupational Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.200: Oxford, Clarendon Press Forno L, Alvord E (1971) The pathology of Parkinsonism: Some new observations and correlations. 

Phrase: "Oxford,"

Phrase: "Clarendon Press Forno L,"

Phrase: "Alvord E (1971"

Phrase: ")"

Phrase: "The pathology of Parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]

Phrase: ":"

Phrase: "Some new observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "and"

Phrase: "correlations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.201: In McDowell F, Markhana C, eds. 

Phrase: "In McDowell F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Markhana C,"

Phrase: "eds."
Processing 00000000.tx.202: Recent Advances in Parkinson's Disease. 

Phrase: "Recent Advances in Parkinson's Disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0725066:Advance [Medical Device]
Processing 00000000.tx.203: Philadelphia, FA Davis, 120-130 Gallyas F (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. 

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "FA Davis,"

Phrase: "120-130 Gallyas F (1971"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   804   C0439133:(f) [Intellectual Product]
   804   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Silver staining of Alzheimer's neurofibrillary changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293950:Silver Staining [Laboratory Procedure]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "by means of physical development."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0871079:physical development [Natural Phenomenon or Process]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.204: Acta Morphol Acad Sci Hung 19:1-8[Medline] German DC, White CL, III, Sparkman DR (1987) Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex. 

Phrase: "Acta Morphol Acad Sci Hung 19"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0268596:ACAD [Disease or Syndrome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]
   766   C0544691:hang [Injury or Poisoning]
   766   C1823998:HANG [Gene or Genome]

Phrase: ":"

Phrase: "1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] German DC,"

Phrase: "White CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "Sparkman DR (1987"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031831:DR [Professional or Occupational Group]
   827   C1707664:DR [Biomedical or Dental Material]
   827   C2348314:Dr. [Conceptual Entity]
   827   C3540849:DR [Idea or Concept]

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "Neurofibrillary tangles in nuclei"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "that"

Phrase: "project to the cerebral cortex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C1709701:Project [Conceptual Entity]
   760   C2700441:Cortex [Plant]
Processing 00000000.tx.205: Neuroscience 21:305-312[Medline] Gibb W, Mountjoy C, Mann D, Lees A (1989) The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome. 

Phrase: "Neuroscience 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "305-312"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gibb W,"

Phrase: "Mountjoy C,"

Phrase: "Mann D,"

Phrase: "Lees A (1989"

Phrase: ")"

Phrase: "The substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ventral tegmental area in Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175405:Ventral Tegmental Area [Body Part, Organ, or Organ Component]
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]
   753   C1704448:Ventral [Spatial Concept]

Phrase: "and"

Phrase: "Down's syndrome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.206: J Neurol Neurosurg Psychiatry 52:193-200[Abstract] Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated PHF proteins display the same biochemical properties as normal *. 

Phrase: "J Neurol Neurosurg Psychiatry 52"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0033872:Psychiatry [Professional or Occupational Group]
   804   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   733 E C0205487:Psychiatric [Functional Concept]

Phrase: ":"

Phrase: "193-200"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Greenberg SG,"

Phrase: "Davies P,"

Phrase: "Schein JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Binder LI (1992"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179302:Binder [Medical Device]
   827   C1706253:Binder [Biomedical or Dental Material]
   827   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "Hydrofluoric acid-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020274:Hydrofluoric Acid [Hazardous or Poisonous Substance,Inorganic Chemical]
  1000   C1171557:hydrofluoric acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "PHF proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0597162:paired helical filament [Cell or Molecular Dysfunction]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "the same biochemical properties as normal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "*."
Processing 00000000.tx.207: J Biol Chem 267:564-569[Abstract/Free FullText] Hansen LA, Masliah E, Galasko D, Terry RD (1993) Plaque-only Alzheimer's disease is usually the Lewy body variant, and visa versa. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "564-569"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hansen LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Masliah E,"

Phrase: "Galasko D,"

Phrase: "Terry RD (1993"

Phrase: ")"

Phrase: "Plaque-only Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "usually"

Phrase: "the Lewy body variant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:Variant [Qualitative Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "and"

Phrase: "visa versa."
Processing 00000000.tx.208: J Neuropathol Exp Neurol 52:648-654[Medline] Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C (1995) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). 

Phrase: "J Neuropathol Exp Neurol 52"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "648-654"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hulette C,"

Phrase: "Mirra S,"

Phrase: "Wilkinson W,"

Phrase: "Heyman A,"

Phrase: "Fillenbaum G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Clark C (1995"

Phrase: ")"

Phrase: "The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.209: Part IX. 

Phrase: "Part IX."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015491:IX [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.210: A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. 

Phrase: "A prospective cliniconeuropathologic study of Parkinson's"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0033522:prospective study [Research Activity]
   783   C1709709:Prospective Study [Research Activity]
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "features in Alzheimer's disease."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1521970:Feature [Qualitative Concept]
   770   C1706388:Feature [Conceptual Entity]
   770   C2346469:Feature [Qualitative Concept]
   770   C2348519:Feature [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.211: Neurology 45:1991-1995[Abstract] Irizarry MC, Growdon W, GomezIsla T, Newell K, George JM, Clayton DF, Hyman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain -synuclein immunoreactivity. 

Phrase: "Neurology 45"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "1991-1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Irizarry MC,"

Phrase: "Growdon W,"

Phrase: "GomezIsla T,"

Phrase: "Newell K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "George JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Clayton DF,"

Phrase: "Hyman BT (1998"

Phrase: ")"

Phrase: "Nigral"

Phrase: "and"

Phrase: "cortical Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   983   C3548436:cortical Lewy body [Cell Component]
   901   C0085200:Lewy Bodies [Cell Component]
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "dystrophic nigral neurites in Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C2674684:Dystrophic neurites [Finding]
   753   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "cortical Lewy body disease"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0752347:Lewy Body Disease, Cortical [Disease or Syndrome]
           Lewy Body Disease
   923   C3548436:cortical Lewy body [Cell Component]
   861   C0085200:Lewy Body [Cell Component]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   729 E C1995017:Bodies [Cell Component]

Phrase: "contain -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "synuclein immunoreactivity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.212: J Neuropathol Exp Neurol 57:334-337[Medline] Ishii T (1966) Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. 

Phrase: "J Neuropathol Exp Neurol 57"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "334-337"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishii T (1966"

Phrase: ")"

Phrase: "Distribution of Alzheimer's neurofibrillary changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "in the brain stem"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006121:Brain Stem [Body Part, Organ, or Organ Component]
  1000   C1306665:Brainstem [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0242767:Stem [Plant]
   861   C1186763:Stem [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "hypothalamus of senile dementia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
   770   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.213: Acta Neuropathol (Berl) 6:181-187[Medline] Kazee A, Cox C, Richfield E (1995) Substantia nigra lesions in Alzheimer's disease and normal aging. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "6"

Phrase: ":"

Phrase: "181-187"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kazee A,"

Phrase: "Cox C,"

Phrase: "Richfield E (1995"

Phrase: ")"

Phrase: "Substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
  1000   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]

Phrase: "lesions in Alzheimer's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0221198:Lesion [Finding]
   770   C1546698:Lesion [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "normal aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]
Processing 00000000.tx.214: Alzheimer Dis Assoc Disord 9:61-67[Medline] Kobayashi K, Miyazu K, Fukutani Y, Nakamura I, Yamaguchi N (1992) Gallyas-Schiff stain for senile plaques. 

Phrase: "Alzheimer Dis Assoc Disord 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0451119:DIS [Intellectual Product]
   804   C1444662:DIS [Finding]

Phrase: ":"

Phrase: "61-67"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kobayashi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miyazu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Fukutani Y,"

Phrase: "Nakamura I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yamaguchi N (1992"

Phrase: ")"

Phrase: "Gallyas-Schiff stain for senile plaques."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.215: Biotech Histochem 67:256-260[Medline] Leverenz J, Sumi S (1986) Parkinson's disease in patients with Alzheimer's disease. 

Phrase: "Biotech Histochem 67"

Phrase: ":"

Phrase: "256-260"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leverenz J,"

Phrase: "Sumi"

Phrase: "S ("

Phrase: "1986"

Phrase: ")"

Phrase: "Parkinson's disease in patients"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.216: Arch Neurol 43:662-664[Abstract] Liang K-Y, Zeger SL (1986) Longitudinal data analysis using generalized linear models. 

Phrase: "Arch Neurol 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "662-664"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Liang K-Y,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Zeger SL (1986"

Phrase: ")"

Phrase: "Longitudinal data analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0010992:Data Analysis [Occupational Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1511726:Data [Idea or Concept]
   827   C1524024:analysis [Functional Concept]
   827   C3245479:data [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "generalized linear models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0023732:Linear Models [Quantitative Concept]
   827   C3161035:Models [Intellectual Product]
Processing 00000000.tx.217: Biometrika 73:13-22 Liu Y, Stern Y, Chun M, Jacobs D, Yau P, Goldman J (1997) Pathological correlates of extrapyramidal signs in Alzheimer's disease. 

Phrase: "Biometrika 73"

Phrase: ":"

Phrase: "13-22 Liu Y,"

Phrase: "Stern Y,"

Phrase: "Chun M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jacobs D,"

Phrase: "Yau P,"

Phrase: "Goldman J (1997"

Phrase: ")"

Phrase: "Pathological correlates of extrapyramidal signs"

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.218: Ann Neurol 41:368-374[Medline] Lowe J, Lennox G, Leigh P (1997) Disorders of movement and system degenerations. 

Phrase: "Ann Neurol 41"

Phrase: ":"

Phrase: "368-374"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lowe J,"

Phrase: "Lennox G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Leigh P (1997"

Phrase: ")"

Phrase: "Disorders of movement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0026650:Movement Disorders [Disease or Syndrome]
   790   C0012634:Disorders [Disease or Syndrome]

Phrase: "and"

Phrase: "system degenerations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011164:DEGENERATIONS [Pathologic Function]
   827 E C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.219: In Graham D, Lantos P, eds. 

Phrase: "In Graham D,"

Phrase: "Lantos P,"

Phrase: "eds."
Processing 00000000.tx.220: Greenfield's Neuropathology. 

Phrase: "Greenfield's Neuropathology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   861   C1540677:neuropathology [Pathologic Function]
   861   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.221: Vol 2. 

Phrase: "Vol 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.222: 6th ed London, New York, Arnold & Oxford University Press, 281-366 Mayeux R, Stern Y, Spanton S (1985) Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. 

Phrase: "6th ed London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023973:London [Geographic Area]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "Arnold & Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "281-366 Mayeux R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "Stern Y,"

Phrase: "Spanton"

Phrase: "S ("

Phrase: "1985"

Phrase: ")"

Phrase: "Heterogeneity in dementia of the Alzheimer type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0019409:Heterogeneity [Qualitative Concept]
   731   C0002395:DEMENTIA OF THE ALZHEIMER TYPE [Disease or Syndrome]

Phrase: ":"

Phrase: "evidence of subgroups."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.223: Neurology 35:453-461[Abstract] McKeith IG, Galasko MD, Kosaka K, Perry DS, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, deVos RAI, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. 

Phrase: "Neurology 35"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "453-461"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McKeith IG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3541296:IG [Idea or Concept]

Phrase: "Galasko MD,"

Phrase: "Kosaka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Perry DS,"

Phrase: "Dickson DW,"

Phrase: "Hansen LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Salmon DP,"

Phrase: "Lowe J,"

Phrase: "Mirra SS,"

Phrase: "Byrne EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Lennox G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Quinn NP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706141:NP [Gene or Genome]

Phrase: "Edwardson JA,"

Phrase: "Bergeron C,"

Phrase: "Burns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006434:Burn [Injury or Poisoning]
  1000   C1550619:Burn [Substance]

Phrase: "A,"

Phrase: "Miller BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Lovestone S,"

Phrase: "Collerton D,"

Phrase: "Jansen ENH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538613:ENH [Gene or Genome]

Phrase: "Ballard C,"

Phrase: "deVos RAI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3539761:RAI [Amino Acid, Peptide, or Protein]
   861   C3539762:RAI [Gene or Genome]

Phrase: "Wilcock GK,"

Phrase: "Jellinger KA,"

Phrase: "Perry RH (1996"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035493:Rh [Element, Ion, or Isotope]
   827   C2699077:Rh- [Classification]
   827   C2699078:Rh+ [Classification]

Phrase: ")"

Phrase: "Consensus guidelines for the clinical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0162791:Guidelines [Intellectual Product]
   760   C0220845:guidelines [Intellectual Product]
   760   C0282423:guidelines [Intellectual Product]

Phrase: "and"

Phrase: "pathologic diagnosis of dementia with Lewy bodies (DLB)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0011900:Diagnosis [Finding]
   748   C1521733:Pathologic [Functional Concept]
   748   C1704338:diagnosis [Qualitative Concept]
   748   C1704656:DIAGNOSIS [Research Activity]
   743   C0332142:Pathology diagnosis [Functional Concept]

Phrase: ":"

Phrase: "report of the Consortium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: "on DLB International Workshop."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   877   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   818   C0085200:Lewy Bodies [Cell Component]
   795   C0011265:dementia [Mental or Behavioral Dysfunction]
   795   C0242262:Workshop [Educational Activity]
   795   C0242821:bodies [Human]
   795   C0497327:Dementia [Mental or Behavioral Dysfunction]
   795   C0677507:Workshop [Manufactured Object]
   795   C1512888:International [Idea or Concept]
   795   C1720176:On [Functional Concept]
   795   C1720294:On [Intellectual Product]
   795   C1995017:Bodies [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.224: Neurology 47:1113-1124[Abstract] McKeith IG, Perry IK, Perry RH (1999) Report of the Second Dementia with Lewy Body International Workshop: diagnosis and treatment. 

Phrase: "Neurology 47"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "1113-1124"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] McKeith IG,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3541296:IG [Idea or Concept]

Phrase: "Perry IK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416378:IK [Gene or Genome]

Phrase: "Perry RH (1999"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035493:Rh [Element, Ion, or Isotope]
   827   C2699077:Rh- [Classification]
   827   C2699078:Rh+ [Classification]

Phrase: ")"

Phrase: "Report of the Second Dementia"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0856416:secondary dementia [Mental or Behavioral Dysfunction]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]
   760   C0565930:/second [Quantitative Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   760   C3273238:Report [Intellectual Product]

Phrase: "with Lewy Body International Workshop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0242262:Workshop [Educational Activity]
   812   C0677507:Workshop [Manufactured Object]

Phrase: ":"

Phrase: "diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.225: Consortium on Dementia with Lewy Bodies. 

Phrase: "Consortium on Dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1513822:Consortium [Professional or Occupational Group]
   790   C1880171:Consortium [Professional or Occupational Group]

Phrase: "with Lewy Bodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.226: Neurology 53:902-905[Abstract/Free FullText] Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). 

Phrase: "Neurology 53"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "902-905"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mirra SS,"

Phrase: "Heyman A,"

Phrase: "McKeel D,"

Phrase: "Sumi SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Crain BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Brownlee LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Vogel FS,"

Phrase: "Hughes JP,"

Phrase: "van Belle G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Berg L (1991"

Phrase: ")"

Phrase: "The Consortium to Establish a Registry for Alzheimer's Disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: "(CERAD"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.227: Part II. 

Phrase: "Part II."
Processing 00000000.tx.228: Standardization of the neuropathologic assessment of Alzheimer's disease. 

Phrase: "Standardization of the neuropathologic assessment of Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0038136:Standardization [Research Activity]
Processing 00000000.tx.229: Neurology 41:479-486[Abstract] Molsa PK, Marttila RJ, Rinne UK (1984) Extrapyramidal signs in Alzheimer's disease. 

Phrase: "Neurology 41"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "479-486"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Molsa PK,"

Phrase: "Marttila RJ,"

Phrase: "Rinne UK"

Phrase: "(1984"

Phrase: ")"

Phrase: "Extrapyramidal signs in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0234133:Extrapyramidal signs [Sign or Symptom]
   797   C0015371:Extrapyramidal disease [Disease or Syndrome]
   760   C0220912:signs [Functional Concept]
   760   C0220913:signs [Manufactured Object]
   760   C0311392:SIGNS [Finding]
   726 E C1547188:Sign [Idea or Concept]
Processing 00000000.tx.230: Neurology 34:1114-1116[Abstract] Morris J, Drazner M, Fulling K, Grant E, Goldring J (1989) Clinical and pathological aspects of parkinsonism in Alzheimer's disease: A role for extranigral factors? 

Phrase: "Neurology 34"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "1114-1116"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Morris J,"

Phrase: "Drazner M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fulling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0443225:Full [Qualitative Concept]

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Grant E,"

Phrase: "Goldring J (1989"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological aspects of parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0205469:Pathological aspects [Functional Concept]
   737   C1547011:Aspect [Quantitative Concept]
   737   C1879746:Aspect [Qualitative Concept]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "A role for extranigral factors?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.231: Arch Neurol 46:651-657[Abstract] Mufson EJ, Mash DC, Hersh LB (1988) Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease. 

Phrase: "Arch Neurol 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "651-657"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mufson EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Mash DC,"

Phrase: "Hersh LB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0085200:Lewy Body [Cell Component]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]

Phrase: "(1988"

Phrase: ")"

Phrase: "Neurofibrillary tangles in cholinergic pedunculopontine neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.232: Ann Neurol 24:623-629[Medline] Parvizi J, Van Hoesen GW, Damasio A (2001) The selectivity vulnerability of brainstem nuclei to Alzheimer's disease. 

Phrase: "Ann Neurol 24"

Phrase: ":"

Phrase: "623-629"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Parvizi J,"

Phrase: "Van Hoesen GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018387:GW [Geographic Area]

Phrase: "Damasio A (2001"

Phrase: ")"

Phrase: "The selectivity vulnerability of brainstem nuclei"

Phrase: "to Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.233: Ann Neurol 49:53-66[Medline] Perry RH (1986) Alzheimer's disease and related disorders. 

Phrase: "Ann Neurol 49"

Phrase: ":"

Phrase: "53-66"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perry RH (1986"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035493:Rh [Element, Ion, or Isotope]
   827   C2699077:Rh- [Classification]
   827   C2699078:Rh+ [Classification]

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "related disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.234: Br Med Bull 42:34-41[Medline] Richards M, Stern Y, Marder K, Cote L, Mayeux R (1993) Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease and normal elderly individuals. 

Phrase: "Br Med Bull 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0007452:Bull [Mammal]
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "34-41"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Richards M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Stern Y,"

Phrase: "Marder K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cote L,"

Phrase: "Mayeux R (1993"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Relationships between extrapyramidal signs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0439849:Relationships [Qualitative Concept]
   737 E C1705630:Relationship [Idea or Concept]
   737 E C1706279:Relationship [Idea or Concept]
   737 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "cognitive function in a community-dwelling cohort of patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0392335:cognitive function [Mental Process]
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1516691:Cognitive [Functional Concept]
   742   C1705273:Function [Intellectual Product]

Phrase: "with Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "normal elderly individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]
Processing 00000000.tx.235: Ann Neurol 33:267-274[Medline] Samuel W, Galasko D, Masliah E, Hansen L (1996) Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. 

Phrase: "Ann Neurol 33"

Phrase: ":"

Phrase: "267-274"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Samuel W,"

Phrase: "Galasko D,"

Phrase: "Masliah E,"

Phrase: "Hansen L (1996"

Phrase: ")"

Phrase: "Neocortical Lewy body counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0439157:counts [Quantitative Concept]
   779 E C0750480:Count [Activity]
   779 E C1705566:Count [Quantitative Concept]

Phrase: "correlate with dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "in the Lewy body variant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205419:Variant [Qualitative Concept]
   734   C0085200:Lewy Body [Cell Component]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.236: J Neuropathol Exp Neurol 55:44-52[Medline] (1997) SAS/STAT Software: Changes and Enhancements through Release 6.12. 

Phrase: "J Neuropathol Exp Neurol 55"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450382:55 [Intellectual Product]
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "44-52"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "(1997"

Phrase: ")"

Phrase: "SAS/STAT Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: ":"

Phrase: "Changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "Enhancements through Release 6.12."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   726   C2349975:Enhancement [Activity]
Processing 00000000.tx.237: Cary, NC, SAS Institute, Inc Smith MA, RudnickaNawrot M, Richey PL, Praprotnik D, Mulvihill P, Miller CA, Sayre LM, Perry G (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. 

Phrase: "Cary,"

Phrase: "NC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SAS Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Inc Smith MA,"

Phrase: "RudnickaNawrot M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Richey PL,"

Phrase: "Praprotnik D,"

Phrase: "Mulvihill P,"

Phrase: "Miller CA,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Perry G (1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Carbonyl-related posttranslational modification of neurofilament protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0033666:Protein Modification, Post-Translational [Molecular Function]
           Post-Translational Modification
           Protein Modification
   774   C2263112:protein modification [Molecular Function]
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]

Phrase: "in the neurofibrillary pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "of Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.238: J Neurochem 64:2660-2666[Medline] Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) -synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. 

Phrase: "J Neurochem 64"

Phrase: ":"

Phrase: "2660-2666"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Crowther RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Jakes R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Goedert"

Phrase: "M ("

Phrase: "1998"

Phrase: ") -"

Phrase: "synuclein in filamentous inclusions of Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "dementia with Lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.239: Proc Natl Acad Sci USA 95:6469-6473[Abstract/Free FullText] Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F (1994) Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictor's Study. 

Phrase: "Proc Natl Acad Sci USA 95"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "6469-6473"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stern Y,"

Phrase: "Albert M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Brandt J,"

Phrase: "Jacobs DM,"

Phrase: "Tang MX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025885:MX [Geographic Area]
   861   C0445039:MX [Finding]
   861   C1551087:Mx [Quantitative Concept]

Phrase: "Marder K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Bell K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Devanand DP,"

Phrase: "Bylsma F (1994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Utility of extrapyramidal signs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0582205:utility [Organization]

Phrase: "and"

Phrase: "psychosis as predictors of cognitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0033975:Psychosis [Mental or Behavioral Dysfunction]
   760   C0349204:Psychosis NOS [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "functional decline,"

Phrase: "nursing home admission,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0184666:admission [Health Care Activity]
   827   C0809949:Admission [Health Care Activity]
   734   C0028688:Nursing home [Health Care Related Organization,Manufactured Object]

Phrase: "and"

Phrase: "death in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: ":"

Phrase: "prospective analyses from the Predictor's Study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]
Processing 00000000.tx.240: Neurology 44:2300-2307[Abstract] Tabaton M, Schenone A, Romagnoli P, Mancardi GL (1985) A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. 

Phrase: "Neurology 44"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "2300-2307"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tabaton M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schenone A,"

Phrase: "Romagnoli P,"

Phrase: "Mancardi GL (1985"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0018229:GL [Geographic Area]
   827   C1423073:GL [Gene or Genome]
   827   C1427674:GL [Gene or Genome]

Phrase: ")"

Phrase: "A quantitative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392762:Quantitative [Quantitative Concept]

Phrase: "and"

Phrase: "ultrastructural study of substantia nigra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0557651:Study [Manufactured Object]
   760   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "nucleus centralis superior in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0228432:Nucleus centralis superior [Body Part, Organ, or Organ Component]
   753   C0007610:Nucleus [Cell Component]
   753   C1282910:Superior [Spatial Concept]
Processing 00000000.tx.241: Acta Neuropathol (Berl) 68:218-223[Medline] Tomlinson BE, Corsellis JAN (1984) Ageing and the dementias. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ":"

Phrase: "218-223"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tomlinson"

Phrase: "BE"

Phrase: ","

Phrase: "Corsellis JAN (1984"

Phrase: ")"

Phrase: "Ageing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "the dementias."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0497327:Dementias [Mental or Behavioral Dysfunction]
   966 E C0011265:dementia [Mental or Behavioral Dysfunction]
   893 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.242: In Hume Adams J, Corsellis JAN, Duchen LW, eds. 

Phrase: "In Hume Adams J,"

Phrase: "Corsellis JAN,"

Phrase: "Duchen LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "eds."
Processing 00000000.tx.243: Greenfield's Neuropathology. 

Phrase: "Greenfield's Neuropathology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   861   C1540677:neuropathology [Pathologic Function]
   861   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.244: London, Edward Arnold, 951-1025 Uchihara T, Kondo H, Ikeda K, Kosaka K (1995) Alzheimer-type pathology in melanin-bleached sections of substantia nigra. 

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "Edward Arnold,"

Phrase: "951-1025 Uchihara T,"

Phrase: "Kondo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ikeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kosaka K (1995"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Alzheimer-type pathology in melanin-bleached sections of substantia nigra."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0030664:Pathology [Biomedical Occupation or Discipline]
   739   C0205469:pathology [Functional Concept]
   739   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.245: J Neurol 242:485-489[Medline] Wakabayashi K, Yoshimoto M, Tsufi S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. 

Phrase: "J Neurol 242"

Phrase: ":"

Phrase: "485-489"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wakabayashi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yoshimoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tsufi S,"

Phrase: "Takahashi H (1998"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "in multiple system atrophy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.246: Neurosci Let 249:180-182[Medline] Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DA (2000a) Progression of parkinsonian signs in Alzheimer's disease. 

Phrase: "Neurosci Let 249"

Phrase: ":"

Phrase: "180-182"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wilson RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Bennett DA,"

Phrase: "Gilley DW,"

Phrase: "Beckett LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Schneider JA,"

Phrase: "Evans DA (2000a"

Phrase: ")"

Phrase: "Progression of parkinsonian signs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.247: Neurology 54:1284-1289[Abstract/Free FullText] Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DA (2000b) Progression of parkinsonism and loss of cognitive function in Alzheimer's disease. 

Phrase: "Neurology 54"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "1284-1289"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wilson RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Bennett DA,"

Phrase: "Gilley DW,"

Phrase: "Beckett LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Schneider JA,"

Phrase: "Evans DA (2000b"

Phrase: ")"

Phrase: "Progression of parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "and"

Phrase: "loss of cognitive function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.248: Arch Neurol 57:855-860[Abstract/Free FullText] Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. 

Phrase: "Arch Neurol 57"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "855-860"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zeger SL,"

Phrase: "Liang KY"

Phrase: "(1986"

Phrase: ")"

Phrase: "Longitudinal data analysis for discrete"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0010992:Data Analysis [Occupational Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1511726:Data [Idea or Concept]
   760   C1524024:analysis [Functional Concept]
   760   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "continuous outcomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.249: Biometrics 42:121-130[Medline]

Phrase: "Biometrics 42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2718322:Biometrics [Occupation or Discipline]

Phrase: ":"

Phrase: "121-130"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

